Dr. Steven Sandberg-Lewis discusses Reflux with Dr. Ben Weitz.

[If you enjoy this podcast, please give us a rating and review on Apple Podcasts, so more people will find The Rational Wellness Podcast. Also check out the video version on my WeitzChiro YouTube page.]

Podcast Highlights

Understanding Reflux: Expert Insights with Dr. Steven Sandberg-Lewis
In this episode of the Rational Wellness Podcast, Dr. Ben Weitz discusses various aspects of reflux with expert Dr. Steven Sandberg-Lewis. They explore the symptoms and types of reflux, including GERD, silent reflux, and bile reflux, and clarify terminologies like GER without D. Factors contributing to reflux, such as gastrointestinal motility issues, structural abnormalities like hiatal hernia, and lifestyle factors, are examined. They also discuss treatment options, ranging from medications like PPIs and histamine blockers to natural treatments including dietary adjustments, herbs, and supplements. The importance of diagnosing and managing Barrett’s esophagus to prevent esophageal cancer is highlighted. Other topics covered include the use of melatonin, vagal tone exercises, and addressing H. pylori infections. The discussion underscores the significance of a holistic and individualized approach to managing reflux and related gastrointestinal conditions.
00:00 Introduction to Rational Wellness Podcast
00:27 Understanding Reflux and Its Symptoms
01:34 Types of Reflux and Their Differences
03:44 Mechanisms Behind Reflux
07:28 Heartburn vs. Reflux
13:52 Medications and Reflux
18:23 Bile Reflux Explained
33:28 Hiatal Hernia and Reflux
37:54 GLP-1 Agonists and Reflux
39:31 Hormone Imbalance and Menopause
42:05 Proton Pump Inhibitors and Reflux Management
47:08 H. Pylori and Its Implications
57:06 Natural Treatments for Reflux
59:11 Vagal Tone and Digestive Health
01:03:04 Dietary Approaches to Reflux
01:07:25 Prokinetics and Gastroparesis
01:08:11 Final Thoughts and Resources


Dr. Steven Sandberg-Lewis has been a practicing Naturopathic Physician for 46 years and he continues to teach at the National University of Natural Medicine.  He wrote an awesome medical textbook, Functional Gastroenterology, which is now in its second addition, and his newest book is Let’s Be Real About Reflux: Getting to the Heart of Heartburn.  His websites are FunctionalGastroenterology.com and HiveMindMedicine.com

Dr. Ben Weitz is available for Functional Nutrition consultations specializing in Functional Gastrointestinal Disorders like IBS/SIBO and Reflux and also Cardiometabolic Risk Factors like elevated lipids, high blood sugar, and high blood pressure.  Dr. Weitz has also successfully helped many patients with managing their weight and improving their athletic performance, as well as sports chiropractic work by calling his Santa Monica office 310-395-3111.

 



Podcast Transcript

Dr. Weitz: Hey, this is Dr. Ben Weitz, host of the Rational Wellness Podcast. I talk to the leading health and nutrition experts and researchers in the field to bring you the latest in cutting edge health information. Subscribe to the Rational Wellness Podcast for weekly updates. And to learn more, check out my website, drweitz. com. Thanks for joining me and let’s jump into the podcast. Hello, Rational Wellness Podcasters. Today, I’m very excited that we’ll be speaking with Dr. Steven Sandberg Lewis about reflux, which is an extremely common gastrointestinal disorder. Heartburn is the main symptom in reflux and is often described as a discomfort or a burning pain felt in the chest or throat.  It occurs at least once a week in about 30 percent of most Americans. And in [00:01:00] up to two thirds of those with IBS, which is, I think, the most common GI condition. Heartburn can be caused by a reflux of the intestinal content up into the throat or esophagus, or it can occur without reflux. Other symptoms of reflux include regurgitation, chronic cough, sore throat, vomiting, hoarseness, chronic throat clearing.

Reflux is often used interchangeably with gastroesophageal reflux disorder, GERD, but this is not correct because there are other forms of reflux, including bile reflux. And silent reflux, which is also known as laryngopharyngeal reflux. The NIH website has now introduced a new term, GER which is gastroesophageal reflux, but not disorder.  Anyway, if you’re confused, I’m confused. And we’re going to try to sort this out a little bit with Dr. Steven Sandberg Lewis.

Dr. Sandberg Lewis is one of the smartest integrative physicians I’ve ever spoken to. He’s a practicing naturopathic physician for 46 years. He teaches gastroenterology at the National University of Natural Medicine, lectures around the world.  He has an awesome medical textbook called Functional Gastroenterology, which is now in its second edition. And his newest book is called Let’s Be Real About Reflux, Getting to the Heart of Heartburn. and Dr. Sandberg Lewis Practices in Portland, Oregon at Hive Mind Medicine. Dr. SSL, thank you so much for joining us.

Dr. Sandberg-Lewis: Yeah, my pleasure. Always good to talk with you.

Dr. Weitz: You know, one of the coolest things about your book is the limericks. Every chapter has a limerick.

Dr. Sandberg-Lewis: Yeah, we wanted to be a little lighthearted about it too.

Dr. Weitz: I want to read the limerick for the introduction. If a hammer is all that you see, then now every problem will be.  So reject a poor hammer and think in a manner that allows things to be seen clearly. So let’s see if we can see clearly about reflux.

Dr. Sandberg-Lewis: Yeah, well, you know what you said, Ben, about GER, Gastroesophageal Reflux, without the D on it.

Dr. Weitz: Yeah,

Dr. Sandberg-Lewis: We add the D when there are symptoms or destruction, you know, of tissue.  But GER, just having reflux itself, is considered a normal phenomenon that occurs perhaps about three times after each meal. But it’s so minimal, and if all the protective mechanisms are in place that move it back down before it does any damage or causes any symptoms, then people don’t even know they have it.  And, you know, we talk about this as like, babies actually have regurgitation as a normal thing.  Most babies spit up in the first year of life and that’s not considered a problem unless they have failure to thrive or start to have other kinds of problems or sleep problems or pain or other signs of distress.  Yeah these reversals in flow of the upper GI tract are normal as long as all the protective mechanisms are in place.

Dr. Weitz: So essentially everything in the GI tract is supposed to go from north to south and anything that moves the opposite direction is what we call reflux.

Dr. Sandberg-Lewis: Yeah.

Dr. Weitz: But why should there be a normal amount when you eat if we have all these contraction of these muscles and this motility mechanism that pushes everything down?

Dr. Sandberg-Lewis: Well, again, There’s so many different mechanisms and that’s why I have a chapter in there on all the mechanisms of this. But if you think about probably the simplest one or the most direct one to discuss is transient lower esophageal sphincter relaxations, right? So TLES for lower esophageal sphincter and relaxations.  So this is a normal mechanism that allows gas and pressure to vent from the stomach out as a belch. And it involves [00:06:00] the lower esophageal sphincter opening much longer than a normal swallow. So normally when someone swallows, something the peristaltic wave moves down, muscularly moves the food or liquid down, and then the lower esophageal sphincter just opens just for a couple of seconds to allow the material to move through, and then it closes tight if it’s working properly.  And that’s its normal state is to be closed and contracted. With TLESRs they’re opening the lower esophageal sphincter and then eventually the upper esophageal sphincter to allow gas to vent from the stomach so people don’t have horrible pain. Some people can’t belch properly and they have a lot of pain. I see a lot of those people. So this lower esophageal sphincter relaxation, this transit type, it’s not that transit.  It’s sometimes up to 20 seconds long, and that’s just way longer than it’s supposed to stay open. [00:07:00] So people who eat in a way that creates more gas in their stomach or small intestine and need to vent it, they can have a lot more reflux. That’s thought to be a major mechanism.

Dr. Weitz: Or people have SIBO who have more gas being produced, right?

Dr. Sandberg-Lewis: Right. Small intestine moving up into the stomach and then venting, you know, can vent either way. It could go down or up, but up is closer.

Dr. Weitz: So what’s the difference between, explain more about what exactly is heartburn as compared to reflux?

Dr. Sandberg-Lewis: So heartburn is that, as you said, subjective sensation of burning or pressure usually in the lower sternal area sometimes slightly lower, but usually right around there, substernal, and it’s not necessarily only caused by reflux of [00:08:00] stomach contents into the esophagus. That’s one cause, but it can also be caused by just pressure differentials. So there’s this thing called Functional heartburn, where there’s actually no reflux at all. If you do all the tests to see if there’s actually reflux, there isn’t, but people have the same symptoms and there’s all kinds of creative ways to explain that nobody really has pinned down the exact mechanism of why people have burning pain, substernal, without having any reflux of stomach contents.  But, it’s fun to make up mechanisms, but, yeah, you don’t have to have reflux of stomach contents into the esophagus to have the same symptoms. An interesting thing, I mention a study in the book where they just found that pressure from, say, more [00:09:00] gas or anything that distends the esophagus, pressure in the esophagus can either trigger burning pain or it can trigger chest pain.  People feel like they’re having a heart attack. And that’s why reflux is, sometimes they say it can mimic a heart attack or angina, because it’s a very similar sensation. And it doesn’t have to be from reflux. It could just be from pressure within the esophagus.

Dr. Weitz: Now it’s generally thought in the medical community that reflux has to do with too much hydrochloric acid, which is why medications are often prescribed that reduce acid.  Like PPIs.

Dr. Sandberg-Lewis: Right. But that’s why I wrote the book. Cause that’s not the whole story.

Dr. Weitz: Of course. And in fact more people have low acid than high acid. [00:10:00]

Dr. Sandberg-Lewis: Yeah. So again, just having pressure of fluid in the esophagus can cause heartburn or chest pain. So it doesn’t have to be acid. Also and that’s called either weakly acid reflux or non acid reflux.  And it’s probably 40 percent of cases of people with heartburn that are tested. But also, Remember this. First of all, there are a number of really good studies that purport that the symptoms of reflux are actually due to inflammation and not burning. It’s like, oh, it’s not actually burning the tissue, it’s causing inflammation in the tissue.  So that’s one thing. And of course, chronic inflammation can lead to Barrett’s esophagus and even cancer of the esophagus, so that’s a big deal. But also, if you think about it, what’s the actual cause? enzyme that digests [00:11:00] protein. The first one is pepsin, right? And pepsin is the active hormone that can digest tissue such as the lining of the lower esophagus or the stomach if it’s not protected properly.  But it’s actually secreted as pepsinogen, a zymogen that doesn’t have that ability. And it’s the acid in the stomach. The pH of the stomach cleaves it and turns it into, from pepsinogen into pepsin. So, again, you don’t actually have to have fluid refluxing. You may just have kind of a mist, you know?  You can have, and we think that’s why, reflux can really aggravate asthma because you’re inhaling pepsin and stomach acid and [00:12:00] possibly slightly not completely digested food in little droplets and inhaling that into your lungs. Wow. Irritant. There are other mechanisms for that as well, but just think about it.  You don’t have to have fluid coming up. You don’t have to have food coming up. It could just be a mist of pepsin and or acid. And the pepsin alone is enough to cause a lot of irritation.

Dr. Weitz: How do we know about this mist? Has that been something that’s been confirmed by some sort of testing?

Dr. Sandberg-Lewis: The The standard tests that are used for reflux don’t actually show that, but there is a test where you can check pepsin levels in the saliva.  And you know, if you’ve got significant amounts of pepsin, like 40 units or more in a saliva specimen, you know for sure that what was in the stomach is now in the throat. [00:13:00] And so it’s especially used to help to diagnose LPR, that laryngopharyngeal reflux that you mentioned. Where people don’t necessarily have heartburn symptoms in the lower sternum, but instead have all these voice and throat symptoms that you mentioned, like clearing and coughing and sore throat and changes in their voice and hoarseness, et cetera.

Dr. Weitz: So for physicians listening, right?

Dr. Sandberg-Lewis:  Your patient doesn’t even need you to order the test. They can go to, I think it’s pepsincheck. com, I think is the website. And they can order a pepsin test. They get three vials to take samples of saliva three different times in the day, and they’ll measure it for pepsin, and then they can share those results with you.

Dr. Weitz: Interesting. For the average patient with reflux, since most people don’t have too much [00:14:00] acid, is there a real rationale for using PPIs, proton pump inhibitors?

Dr. Sandberg-Lewis: Well, of course, there’s proton pump inhibitors and there’s histamine blockers.

Dr. Weitz: Okay. And so like Pepin is an H2 histamine blocker. 

Dr. Sandberg-Lewis: Pepcid AC is a brand name for famotidine the generic, which is a H2 receptor antagonist. Yeah. And I like, I just had a new patient who was having severe, severe cutting pain and he, we know based on his upper endoscopy that he has duodenal ulcers, multiple ones, not just a single solitary one. And he was having so much pain and taking a proton pump inhibitor didn’t do anything for his pain. He got some relief from sucralfate, which is, it’s kind of like [00:15:00] a I call it allopathic, DGL ’cause it kind sos it kind of coats the tissue and relieves it.

Dr. Weitz:  What is it called?

Dr. Sandberg-Lewis:  Suc fate. Suc. Suc crawl fate. It’s S-U-C-R-A-L-F-A-T-E. Huh. Anyway, he got some relief from that, but then he started to have side effects, so he’s now taking famotidine and that has. because it’s an H2 receptor blocker has completely taken his pain away so far. Totally different mechanism.  So again, this is a guy, he’s a guy who tends towards asthma and other allergic tendencies, and so it, it makes a lot of sense if he actually wants to block his acid to, to use this kind of histamine mechanism, rather than try to just shut off the whole proton pump, and a lot of people don’t tolerate that.

Also, like you said when I do Heidelberg testing in my [00:16:00] office to actually measure pH, I used to say, about 25 to 30 percent of people actually are hypersecretors of acid and the other probably 50% underproducing and the rest were normal producers of acid. But what I’m seeing now more and more, I’d say it’s about 50:50.  So about maybe 50 or 40 percent of people are hypersecretors of acid. But this is one thing I think is really important and I think what’s happening is people who have been taking a proton pump inhibitor, when they go in for testing, you know, any kind of testing to see if they have reflux, they have them stop the proton pump inhibitor for seven days.  And then they do the test, and I think that clearly, during that time, they are hypersecreting because [00:17:00] their proton pump inhibitor is not there, so all of that histamine and gastrin, we know gastrin levels go sky high in the blood when you’re taking a proton pump inhibitor, because gastrin is the stomach hormone locally produced that’s trying to trigger you to make more acid, but you can’t because you’ve taken the proton pump inhibitor.  You take that drug away and now you’ve got these really high levels of gastrin and now you’re going to produce huge amounts of acid. So people that get tested for reflux after they’ve already been on a trial of proton pump inhibitors, often look like they produce huge amounts of acid. So I don’t blame anybody for being confused about that and thinking, oh, it’s all about too much acid.  Well, it is once you’ve been taking a proton pump inhibitor for three or four weeks or three or four years, or some of my patients 20 years. I think that, unfortunately, those very good tests, [00:18:00] like the Bravo test and the pH impedance test, they’re, unfortunately, they’re measuring, most of their patients are people that were already put on a proton pump inhibitor, took it away for a week, did the test, and they just look like they create huge amounts of acid, even though that might not be where they started.  Interesting. So what is bile reflux? So bile reflux is when you move down one valve and if the pyloric valve instead of the lower esophageal sphincter is not functioning properly and staying closed.

Dr. Weitz: So this is a valve between the stomach and the small intestine?

Dr. Sandberg-Lewis: Right, and when that valve is hypotonic, or not as functional as it should be, that can allow reflux of small intestine contents into [00:19:00] the stomach, and that alone can then cause a lot of irritation because bile, okay, let’s talk about, so what’s coming up through the pyloric valve.  It’s bile, it’s bacteria and fungus, it’s Brush border enzymes that are produced on the small intestine lining. It’s undigested food, you know, not incompletely digested food. And it’s also pancreatic enzymes, which can also digest fat, protein, and carbohydrate. You know, there are proteases in there really strongly.  So, now you’ve got this soup, and then you might mix it with stomach acid in the stomach, and pepsin, and now it’s a much more complex soup. irritant. And then of course if people have reflux into their esophagus, all of that goes up into the esophagus. But some people it just really irritates their [00:20:00] stomach and that’s called bile gastritis or reactive gastritis.  But if it refluxes into the lower esophagus it can cause the worst kind of reflux heartburn. esophageal irritation. And we think actually is a more potent stimulator of Barrett’s esophagus over time than just regular reflux.

Dr. Weitz: Yeah. I spoke with Dr. Rahbar and he said when he does his endoscopies, patients with SIBO have an increased risk of that bile reflux.  And he feels that potentially indicates fungal overgrowth. I forgot why though.

Dr. Sandberg-Lewis: Well, you know, he I liked, I really liked the way he does his upper endoscopies. First of all, when he’s checking for parasites, often he’ll take a sample of the bile, actual bile from one of the ducts, or if it collects in the duodenum, and he’ll test [00:21:00] that instead of just stool for parasites because we know parasites like to live in the gallbladder. But also he and Dr. Satish Rao can also culture the duodenal contents for fungus as well as bacteria and see the exact, what’s actually overgrown instead of just the breath test that doesn’t tell you, just shows you how much gas they produce.  So yeah he’s very progressive. I love what he does.

Dr. Weitz: One of the fears of reflux is that if it burns the esophagus, it can set up the risk of Barrett’s esophagus and eventually esophageal cancer. So, how do we protect against that? Obviously, we have to reverse the reflux, and part of it’s about the protective factors in the esophagus.

Dr. Sandberg-Lewis: Yeah, so first of all I [00:22:00] mean the best thing you can do is to actually diagnose Barrett’s early, and the, it’s kind of a joke in terms of how few people actually get tested for Barrett’s because if you, if you consider the top four risk factors, being Caucasian, being male, being over 50, and then there’s a whole other list.  So basically, all white guys over 50 should be screened because they have the highest risk. If you add type 2 diabetes any smoking history, and then also having a waist circumference that puts you in the visceral adiposity obesity range. Those are all big risk factors. So, you know, there’s just, there’s a lot of people that should be screened.

And that’s why I wish that the ESOGuard test [00:23:00] had been picked up and used by more doctors, because that’s a non, kind of a non invasive way to take a sample, like you would take a pap smear. You take some tissue from the cervix and the vagina and you can check it microscopically. In this case, they take some scrapings brushings from the lower esophagus by putting a tube down through the nose and down into the lower esophagus expanding this little bulb on the bottom, pulling it up through the lower esophagus, and then deflating it again and taking it out. It takes like five minutes. And then they can check it for DNA adducts that are common for Barrett’s esophagus. Or esophageal cancer. So it’s just a great little screening tool.  Unfortunately, it didn’t catch on and I hope that over time it will. I talk about it in the chat. Is that a test that you do? It is. It, you [00:24:00] know, it’s not available everywhere, but we do have it available here in Portland. There’s a hospital that where you can send patients where they do it. ESOGuard test, but anyway in terms of besides early diagnosis once you know that the patient has it.

There’s so many things you can do. So first of all you can use green tea extract, you can use vitamin A and C, excuse me, vitamin C and E, you can use of course diets that are higher in fruits and vegetables, and we often will use a, an extract of berries, like a frozen berry extract, so they can get a real good dose of anthocyanidins and beta carotene through that each day.  And then folic acid, and also riboflavin those B vitamins have been shown to be really protective against further [00:25:00] development. And then you know, like you said, probably the most important thing is actually treat the cause behind the reflux if you can, so they don’t continue to have reflux and don’t have that chronic inflammation.

I mean, the good news is that, Even in men that have a higher risk of this, you know, if you know the patient has Barrett’s esophagus, you can periodically biopsy those areas and make sure there’s no dysplasia occurring, because mild, moderate, and severe dysplasia, just like with a pap smear, you know, looking for dysplasia, those are the precursors to esophageal cancer in this case.  when you check in the lower esophagus. So you can prevent dysplasia and prevent the whole process from going forward to cancer with a lot of these factors. And of course, all the lifestyle factors that help to correct that need for transient lower esophageal sphincter [00:26:00] relaxations and gas and all those things that fuel reflux.  We talk about that in the chapter on lifestyle issues too.

Dr. Weitz: What about using nutrients that would directly affect the esophagus. I’ve had some patients slowly sip on some slippery elm in water to try to soothe the esophagus and produce some healing.

Dr. Sandberg-Lewis: Yeah. Some of the, probably the more healing herbs that we use for that are the DGL, you know, the licorice without the glycyrrhiza, unless your patient’s also hypoadrenal, and then you might want to use some whole licorice as well. Slippery Elm Althea, which is marshmallow root Aloe Vera, all those things can really help allay irritation, chronic inflammation and often heal tissue. But melatonin is another [00:27:00] really important one, and that’s why there’s a whole chapter in the book on melatonin, because it’s It just really impresses me that there’s a study that shows that people with the lowest melatonin levels are people who have duodenal ulcers.  People with the slightly better levels have erosive esophagitis, and people with the best levels of melatonin in their system are people that have NERD, which is non erosive reflux disease. They don’t have any damage. from reflux, even if they have reflux. So in all three cases, you’re talking about people.

Dr. Weitz: And what do we think would be a reasonable dosage of melatonin? Because people are all over the place on how much melatonin they use. When it comes to sleep. [00:28:00] Some people are advocating three. I’ve heard people recommend 3. There’s some herbal melatonin now that Deanna Minich is recommending at super low dosage.  And yet on the cancer front, people are recommending two or three hundred milligrams per day. Yeah, they’re, yeah, I know when I read your book, you were talking about the levels in the gut as being like 400 times the levels in the bloodstream. So I’m wondering, would that lead to a recommendation of a higher dosage of melatonin to take for this purpose?

Dr. Sandberg-Lewis: Yeah, so, typically we use 3-6 mg.

Dr. Weitz: Which is to the sleep recommendation.

Dr. Sandberg-Lewis: Yeah, yeah. And, on the other hand, if you consider one of the risk factors for [00:29:00] Barrett’s esophagus is sleeping less than 6 hours.

Dr. Weitz: Oh, really?

Dr. Sandberg-Lewis: Yeah, it’s on that list with the other things I mentioned.

Dr. Weitz: Oh, okay. So,

Dr. Sandberg-Lewis: again, if you can improve someone’s sleep and if you can balance their melatonin, cortisol, and DHEA, You know, because there’s a big relationship there, right?  When cortisol is highest in the morning and drops down to its lowest at night, that’s what allows melatonin to come up. And then melatonin drops as cortisol’s coming up in the morning. And so they take turns, you know, they’re in phases. And so, if you can improve sleep, if you can balance cortisol and other stress hormones so that people make more of their own melatonin, I think that’s probably the best.  I probably don’t, I don’t have people take melatonin as a pill, as much as I try to really improve their sleep and their stress hormone balance.

Dr. Weitz: How do you help them improve their sleep?

Dr. Sandberg-Lewis: Oh, yeah. Well, first of [00:30:00] all if you find somebody who’s got high cortisol at night, instead of its lowest level, right.  That’s really going to help them sleep. If you can help modulate it with adapted genic herbs especially ashwagandha. Okay.

Dr. Weitz: Phosphatidylserine.

Dr. Sandberg-Lewis: Phosphatidylserine is one that we think works through the ACTH, negative feedback loop. And then sometimes if they also, as well as having a high cortisol, they also have a low DHEA. Bringing up the DHEA will help modulate the cortisol down toward where you want it. So it’s a balancing act there.  And then of course there’s sleep hygiene and, getting people off of their screens late into the night and all that kind of thing. 

Dr. Weitz: Getting away from the blue light, et cetera.

Dr. Sandberg-Lewis: Yeah. Or neurofeedback and other forms of biofeedback that can help. The gut and the nervous system produce better [00:31:00] levels of these sleep hormones and protective, GI protective hormones.  So again, yeah, it’s a, there are lots of ways to approach it, but if you can get their melatonin and its related hormones in balance, that’s probably even better. And, you know, get them sleeping closer to eight hours.

Dr. Weitz: Now there’s a number of categories of drugs that increase your risk of reflux. So we have drugs such as NSAIDs, corticosteroids, alcohol, bisphosphonates, which are the anti resortive drugs for osteoporosis that we know have esophageal issues benzodiazepines, which people often use for sleep or for stress, and calcium channel blockers. [00:32:00]

Dr. Sandberg-Lewis: Yeah, so things that disrupt the muscle function, smooth muscle function anticholinergics can be a problem there too. But you mentioned about the bisphosphonates, I think, so there’s two categories really, there are drugs that irritate the esophagus, and can make reflux worse, the symptoms worse, and bisphosphonates are in that group.  You know, that’s why you have to be able to stand or sit for at least 30 minutes after you take it, so it won’t pool in your esophagus, because it’s so irritating, and NSAIDs are the same way. But then there’s the other group that affect the muscle tone or other factors that actually can cause reflux, and you mentioned those.

Dr. Weitz: And that whole thing about the position you’re in, that’s super important for managing reflux, meaning patients who you’re trying to help relieve their reflux, you want to recommend that they not eat a [00:33:00] meal and then put their feet up or recline that they sit upright. Maybe I often will suggest going for a walk just to push the food down and decrease the likelihood that things will come up.

Dr. Sandberg-Lewis: Yeah and that’s the reason why. finishing food by at least three hours before you lie down to go to sleep is a great idea. And some people do much more than that, more than three hours sometimes. But I think you might want to also consider people that have reflux symptoms that have a hiatal hernia, sliding hiatal hernia.  And then those who don’t, you know, they have reflux, but don’t have a hiatal hernia. Really when you think about it, If you have a sliding hiatal hernia and it’s up, cause it can slide up and down.

Dr. Weitz: Right, so let’s explain to the public what we’re talking about. You’re talking about this opening in the diaphragm [00:34:00] and the stomach slides up through that opening, correct?

Dr. Sandberg-Lewis: Correct.  Yeah, so, of course, the esophagus is in the chest with the heart and the lungs.

Dr. Weitz: Right.

Dr. Sandberg-Lewis: Then there’s the diaphragm muscle, and it separates everything that’s in the chest from what’s in the abdomen. The stomach’s in the abdomen, so it has to meet up with the esophagus, and they’re in two different parts of the body.  So there’s an opening called the hiatus, which means window in Latin the hiatus of the diaphragm. That allows the esophagus to meet up with the stomach that’s underneath the diaphragm. And so a sliding hiatal hernia, let’s say this is the hiatus here in the diaphragm and here’s the stomach hiatal hernia is typically about two centimeters is an average small one.  Two centimeters of the stomach has moved into the chest. Sometimes three centimeters. If they’re [00:35:00] really big, they’re larger than five centimeters. So even having this, basically a less than an inch of the stomach in the chest can cause all kinds of symptoms. And if you think about it, the diaphragm is a muscle.

It’s smooth muscle, just like the lower esophageal sphincter, which is part of the esophagus. The esophagus and the lower esophageal sphincter are running through that hiatus in the diaphragm, which is a muscle and actually has to what are called CRUX, C R U X, and it means like a cross, and these are like little extensions of the muscle of the diaphragm that hug the lower esophageal sphincter.

So the lower esophageal sphincter is a muscle. and it’s surrounded by the diaphragm muscle. You put those together and you have a [00:36:00] really good system. If you move the lower esophageal sphincter, which is right here at the top of the stomach, up two centimeters or three centimeters, now it doesn’t have its big brother around it, hugging it anymore.  it’s going to be way weaker. So those transient lower esophageal sphincter relaxations and regular openings, all of that can be a lot weaker. So having a high sliding hiatal hernia just adds a whole new ball of wax to the whole reflux issue. That’s why it’s really important to deal with it if you can.

Dr. Weitz: What do you think about patients getting that surgery, the Nissen fundoplication?

Dr. Sandberg-Lewis: Yeah, Nissen fundoplication is, often a pretty effective treatment. There are visceral manipulation and exercise treatments that [00:37:00] can correct the smaller ones.

Dr. Weitz: Yeah. I often use the technique I learned from you.

Dr. Sandberg-Lewis: Yeah. But yeah, for persistent ones or the really large ones the ones that are greater than three centimeters that just won’t stay down, or if someone has hypermobility syndrome, like Ehlers Danlos Syndrome, where their tissues just don’t hold things in place as much, those people are really prone to lower esophageal sphincter laxity and hiatal hernia, sliding hiatal hernia, that you can put it back in place, but it won’t stay.  So, there are definitely some good reasons to, to use Nissenfund application if it’s needed as a last resort.

Dr. Weitz: Now we’re talking about medications and we know that anything that alters esophageal or gastric motility, is going to increase the risk of reflux. And we now have this class of medications that is taking the [00:38:00] country by storm, that we’re now seeing millions of people use, and we’re probably going to see Tens of millions on soon.  And these are the GLP 1 agonist drugs like Ozembic, which people are using for weight loss. And now they’re being touted for 20 other health benefits supposedly. And we know that they work partially by slowing gastric motility.

Dr. Sandberg-Lewis: Right, slowing down the absorption of carbohydrates. They, really, GLP and the other incretins that are normally produced in the small intestine, they are amazing.  They’re really important. for treating diabetes and insulin resistance and helping people lose weight and normalize their blood sugar. 

Dr. Weitz: But all these GI disorders that are related [00:39:00] to decreased motility are likely to be exacerbated.

Dr. Sandberg-Lewis: It’s very, yeah it’s a side effect that can definitely be an issue. 

Dr. Weitz:  I asked Dr. Pimentel and he said looking at breath tests and and microbiome of these patients, it’s totally messed up.

Dr. Sandberg-Lewis: Yeah, and I’m, I think that there’s another drug that has the GLP 1, but also has another in Cretin as well Terzapatide. Yeah. And I think that one’s gonna turn out to be a better choice because, again, when they started giving all women going through menopause estrogen back in the 1960s, It was a miracle.  I mean, their hot flashes were better, they slept better, all kinds of things were better. Then they found out a lot of them are getting cancer of the uterus. Because you’re only [00:40:00] using one hormone. And what about the progesterone? They balance each other. They’re… 

Dr. Weitz: Not to mention it was horse estrogen.

Dr. Sandberg-Lewis: Well, yeah, I mean, you can, you could argue about the ratios of E1, E2, and E3. 

Dr. Weitz: Horse estrogen.

Dr. Sandberg-Lewis: The thing is,

Dr. Weitz: we gave women horse estrogen.

Dr. Sandberg-Lewis: The thing is that I think whenever you give a single hormone and you don’t give its sister or brother hormone, the other incretins in this case you’re looking for trouble.  You’re gonna, because every, basically every or most of the endocrine organs in the body have these paired balancing hormones. And if you look, even look at the thyroid, We know that thyroxin demineralizes bone if you have too much of it. Thyrocalcitonin, also produced in the thyroid, builds [00:41:00] bone.  So if you just give one hormone, you can really cause imbalances. You don’t get that fine tuning that we normally have. So that’s why I think we’re going to find that using the incretins as a group, instead of just semaglutide by itself, It’s probably going to be better. But of course, if you can get your patient to make more incretins, just like if you get your patient to make more melatonin, instead of having to give it to them, that’s even better.  And there’s lots of good ways to do that.

Dr. Weitz: Right. But don’t you think we’re likely to see a big increase in reflux?

Dr. Sandberg-Lewis: If you consider that it’s, So common already. You mentioned 30 percent of the population has reflux at least once a week and maybe 20, 20 percent has it on a regular basis.  More often than that, it’s already so common. Yeah, again, you can’t fool mother nature. You can’t mess [00:42:00] around and not use a balanced approach and not expect to do well.

Dr. Weitz:  When you have patients who are taking proton pump inhibitors, how do you handle that? If you have ’em, stop them.  How do you wean ’em off?

Dr. Sandberg-Lewis: So first of all, the newest recommendations from the American College of Gastroenterology for Barrett’s esophagus is for patients to be offered a proton pump inhibitor to take at least once a day. indefinitely. They have found that that does reduce the risk of dysplasia and conversion to esophageal cancer.  So currently, its changed. Three years ago, they didn’t say that. They said it wasn’t beneficial. And now the research shows that it is. I let patients know that. I let them know that unless they have bad side effects or for some other reason, can’t take a proton pump inhibitor, taking one [00:43:00] once a day, if they have Barrett’s is the recommendation.

Dr. Weitz: And what if they don’t have Barrett’s and they’re worried about?

Dr. Sandberg-Lewis: If they don’t have Barrett’s and they just have heartburn and you think it’s reflux or you know, it’s reflux. Right. Certainly if they have erosive esophagitis. You know, there’s LA grade A through D esophagitis, and D is the worst, but if they have grade C or D reflux esophagitis, I recommend that they do take a proton pump inhibitor until it’s healed.  And a lot of those people may need it long term unless you can treat the causes of their reflux. So there’s a place for it. And it really can heal. And it’s just, those are the people that they take a proton pump inhibitor and it’s like a miracle from the first dose. because all that incredible burning pain that they’re having all the time from a raw esophagus that’s eroded [00:44:00] is suddenly gone.  It usually works really well for those people. So you use it until it’s healed and you work on the underlying causes while you’re doing that. If someone’s just taking a proton pump inhibitor because that’s all their doctor knew for their heartburn, a lot of times it’s not even working. 40 percent of the time it doesn’t work, and people still take it because, well, my doctor told me to.

Those are people that, you can definitely wean them off if it’s not helping anyway. And a lot of people that it is helping, you can wean them off too if you can treat the underlying causes. So I have a little step down approach to it where what we often do is we will Let’s say they’re taking a proton pump inhibitor when you first see them.

They’re taking it twice a day, maybe at high potency. We’ll cut it down to the lower potency twice a day. [00:45:00] And then if they’re doing just as well as they were before, then we’ll cut it down to once a day. If they start having reflux, that part of the day where they’re not taking their second dose, We’ll, you know, we’ll use these, either a natural medicine to help that, or we’ll use famotidine, that H2 receptor antagonist, which is, in my experience, a lot less prone to creating this rebound hypersecretion.

We keep doing that, you know, if it’s been, it could be two weeks, it could be a month, they’re realizing, okay, I’m doing fine now. Then, we take the other dose of the proton pump inhibitor out. And if they need it, we might use the famotidine. So they’re taking it once or twice a day on the days they’re not taking the proton pump inhibitor.

And now they’re taking maybe the proton pump inhibitor Monday, Wednesday, Friday, and Saturday. [00:46:00] And they’re just taking the famotidine on the other days. And if they’re doing just fine, we go even further and we have them just take it Monday, Thursday, and Sunday, you know, every third day. And it’s a very slow process.

When someone’s been on a proton pump inhibitor for decades sometimes, even just years, you really have to do it slowly. But if you do it slowly, you can normalize that rebound hypersecretion. There’s one study that states that rebound hypersecretion can, in some cases, can go as long as 8 months. Wow. So, yeah, you know, if someone’s been taking a proton pump inhibitor for a long time, take your time, have them take their time and say, Hey, look, if a year from now, you’re off of this drug that you don’t need, because we’ve assessed you don’t need it what’s the harm?  You’ve been taking it for 5 [00:47:00] years already, right? If you just try to stop it quickly, you will fail. So let’s do it right.

Dr. Weitz: H. pylori infection. Now, the story about H. pylori infection, for people who don’t know, is that this is a bacteria that burrows itself into the wall of the, into the stomach, and that Dr. Marshall proved a number of years ago that this was the cause of ulcers. And he did it by drinking H. pylori solution, gave himself an ulcer, proved that he had it, and then used triple antibiotic therapy, two antibiotics along with the PPI and cured himself of ulcers. And so the thought was that these ulcers derive because the [00:48:00] stomach starts secreting more acid in response to the H. pylori. And a lot of doctors feel that H. pylori infection is one of the causative, possible causative factors of reflux. I know that you definitely disagree with that.

Dr. Sandberg-Lewis: It’s a, it’s just a misconception. All the, virtually all the research shows that H. pylori is protective against reflux, Barrett’s esophagus, and esophageal cancer.  So to me it makes no sense to even test somebody for H. pylori if they already have reflux or Barretts. And then, if they have an upper endoscopy. They’re going to be tested because you, that’s part of an upper endoscopy, and they’re going to get treated if they have it. [00:49:00] Luckily, the research that I looked into says that if you treat the H. pylori once you already have Barrett’s, it doesn’t seem to make it all worse. It doesn’t make the reflux worse, but 100 percent of the world’s population, we think, had H. pylori in their stomachs for at least 60, 000 years until we started killing it in the 1990s. And yeah, it can cause duodenal ulcers, stomach ulcers.  It can cause gastritis, inflammation of the stomach lining, and it can cause a really rare form of lymphoma that occurs in the stomach called maltoma. And there are some other conditions that it can aggravate. It can aggravate psoriasis and a number of other things, chronic hives. There are other things that it could be associated with in adults.

But in children, it’s [00:50:00] very important for maturing the immune system, especially in the gut where most of the immune system is. And so our concern and Dr. Blaser writes about this very eloquently, the concern is we’ve gone from 100 percent of the world’s population having this protective thing in the first few years of your life to mature your immune system to having less than five percent of children in the US have it now when they need it. And, it’s also, it reduces the risk of hay fever, food allergy, respiratory allergy, asthma, Crohn’s disease. Really good meta analysis showing, a bunch of studies that show that it really helps protect against Crohn’s disease.

Dr. Weitz: Is there any way that we know of to increase H. pylori?

Dr. Sandberg-Lewis: Well, yeah Blaser has a great solution. And he says, so he thinks once the FDA understands this process, which might be 30 years from now when babies are born, they will give them a multi strain probiotic of H. pylori, not just one strain, several strains seems to be better than one, and they’ll just give the, to the kids, and then they’ll have that protection.  reduce risk of autoimmune diseases, allergic triad, and reflux and its complications. And then, if when they’re older, they develop ulcers, or they look like they might be at risk for stomach cancer, if there’s a family risk, then they’ll kill it with triple therapy, but they will give it to the newborns that need it.  So, so much.

Dr. Weitz: Yeah. We do the GI map stool test quite a bit, and that includes H. pylori and the virulence factors.

Dr. Sandberg-Lewis: Yeah. Now, you know, I have a bug about that, and that is I have a slide in my lecture on H. pylori and it says, how natural doctors get it wrong. My feeling is if you’re going to do stool panels.  Do a stool panel that doesn’t have H. pylori. I use, can I say names of labs? 

Dr. Weitz: Yeah, sure.

Dr. Sandberg-Lewis: I use Doctor’s Data Origin, sometimes Genova, but mostly Doctor’s Data. They correctly on their panels, they’re checking for parasites and they’re checking for fungus and they’re checking for beneficial bacteria.  They check for pathogens like Clostridium Difficile, but they don’t test for H. pylori unless you do a special order for it, because I don’t want to test my patients. that just have reflux. I [00:53:00] don’t want to test them for H. pylori and then have to kill their H. pylori, which has nothing to do with causing their reflux.

Dr. Weitz: Well, I don’t feel any compulsion to having to kill their H. pylori just because it comes up.

Dr. Sandberg-Lewis: Well, that’s the thing though, is a lot of doctors, when they see that it’s a positive, and for good reason, the dictum in H. pylori The world of H. pylori is test and treat, meaning if you test somebody, you’re supposed to treat them,

Dr. Weitz: right?

Dr. Sandberg-Lewis: So I don’t even want to test them unless I have a good reason to because they have a disease that’s associated with a more virulent form.

Dr. Weitz: Now, I’m pretty sure that you write in your book that if we use like the triple antibiotic therapy, which is the standard for killing H. pylori, that can increase the risk for GERD, right?  Or [00:54:00] reflux?

Dr. Sandberg-Lewis: I think the mechanism there is I’ve seen people develop SIBO and IMO. Okay. Overgrowth after triple therapy, because it’s kind of a perfect way to get Overgrowth, right? You’ve taken two antibiotics that really affect the balance. And then you’re taking a proton pump inhibitor, which has more negative effects on the microbiome probably than the antibiotics, but you put all three together and you’re really, really likely to get overgrowth.  So yeah, you can definitely get reflux when you didn’t have it before. I see that a lot, I don’t want to talk people out of. Treating H. pylori or saying they’re doctors wrong because it’s test and treat. I wonder what the

Dr. Weitz: effects are if we treat it with mastic gum and the other natural treatments.

Dr. Sandberg-Lewis: What you do that and then you retest them and you see if it worked.

Dr. Weitz: Sometimes, sometimes we just base on how they feel.

Dr. Sandberg-Lewis: Yeah, mastic is a wonderful demulsant, it just it can heal [00:55:00] ulcers. We know that it’s used For thousands of years for that purpose and gastritis. It’s really soothing and healing And there are some studies that show a little tendency for it to reduce H pylori But you know no single agent kills H. pylori. That’s why triple therapy and quadruple therapy are what they are, right? Right. So there’s no prescription or natural thing that’s going to work on its own. It’s going to have to be a combination. And really if you’re thinking the H. pylori really needs to be killed, then you need to retest.

And the thing about, one thing I’ll say about the GI map, their test, if I’m correct, when I look at it, their H. pylori test is DNA. It’s PCR DNA. Correct. And that is not a standard test [00:56:00] for H. pylori. It’s their own test that they made up. I think it’s great to be creative, but I’m not going to di I’m not going to diagnose H. pylori based on that because it’s not a standard test. So if it comes back positive, I run a standard test, which would be H. pylori IgG blood antibody, Or even better, H. pylori stool antigen, you know, which is a protein in the stool, or H. pylori breath test. Those are definitive tests, and the breath test, as well as the stool antigen, those are telling you that you have it right now.  The blood antibody, if you got treated, it could still be positive, even if it’s gone. You can’t use that to retest. But the stool antigen or the breath test, they’re going to, they’re going to turn negative. Once you’ve treated it properly. So, I just say, if you’re going to do that and nothing wrong with the [00:57:00] GI map, double check it with a standard test.  If you get a positive.

Dr. Weitz: Let’s go through some of the most important treatments that we want to think about. You’ve mentioned some of them already, but we were trying to find some of the underlying causes. So we want to see if they have. Structural issues like some of the ones you’ve talked about, like hiatal hernia problems with the lower esophageal sphincter whether they have issues with motility we want to see if they have SIBO, because SIBO can lead to gas and affect motility, and then correct those.  We want to rule out food sensitivities, right? Do you regularly rule out food sensitivities or is that something you look at sometimes?

Dr. Sandberg-Lewis: You know, I tend to use diets that initially are restrictive of certain food groups, and [00:58:00] I tend to do that as more of an elimination diet rather than testing, but it’s an important thing.  I know personally from my own health, and I never talk about my own case, but when it comes to reflux, If I want to have reflux, all I have to do is eat white potato. Really? If I eat white potato in any form, more than a couple teaspoons, I’m going to have reflux. Now, of course, I do a lot of things right in terms of my overall diet, but that’s the one thing I know will do it.  And I have other patients that it could be that, it could be sugar, it could be one patient it’s kiwis and other citrus fruit. Some people it’s dairy. They cut out dairy products or lactose containing dairy products and their reflux completely goes away. Some patients, Especially celiac disease and non celiac gluten intolerance patients.  They take the gluten out. They don’t have reflux anymore. So you’re [00:59:00] absolutely right. That’s a big deal. Not everybody’s designed to eat everything you can buy in a supermarket.

Dr. Weitz: Right. So, what are some of the other treatment approaches?

Dr. Sandberg-Lewis: Yeah. So again, the way I did it in my chapter on natural treatments is I did it by mechanism, right?  Which I think is a good way to think about it. So if you know on somebody’s upper endoscopy it, the report says, the lower esophageal sphincter was gaping open. I’m going to do things to help with parasympathetic tone, diaphragmatic breathing exercises, getting good diaphragmatic tone, help to get the big brother to hug the little brother.  You can use vagal toning exercises. You can use what I use a lot.

Dr. Weitz: What do you, what are your favorite vagal toning exercises?

Dr. Sandberg-Lewis: Well, actually my favorite is alternate nasal [01:00:00] breathing together with diaphragmatic breathing.

Dr. Weitz: Alternate nasal breathing. I never, yeah,

Dr. Sandberg-Lewis: it’s called a Pranayama in yoga. Okay. You breathe out of one nostril and I breathe out of the other one.  It’s on my website, I have a description and you can, it’s just Pranayama explains it, but it’s a really good brain balancing, vagal balancing exercise along with toning of the diaphragm. But in addition, we know from the heart math research, right. Feeling a sense of gratefulness before meals can really improve vagal tone.  So using, if people like using some kind of an app, they can use HeartMath. The HeartMath folks and other companies, they make a Biofeedback device that gives you heart rate [01:01:00] variability, biofeedback, and you can learn to improve your heart rate variability, which is a direct result of good vagal tone.  And it’s very enjoyable kind of little games that you can play with your vagus nerve.

Dr. Weitz: What about vagal nerve stimulating devices?

Dr. Sandberg-Lewis: You know, there’s more and more versions of that now that are less scary than the ones they used to have, and I haven’t started using those, but I’m sure we’ll see more and more data about those as time goes on.  It makes sense. It passes through here. One of the ways that I just test for vagus nerve tone is to look at the person’s rise in their palate when they say ah. And I want to see symmetrical rise and a brisk rise. So I do that as part of my physical exam, but yeah, other things that I do for the lower [01:02:00] esophageal sphincter tone is Huperzine A, right?  Huperzine A, which is a anti cholinesterase. It’s a cholinesterase

Dr. Weitz: Often included in brain formulas.

Dr. Sandberg-Lewis: Yeah, because acetylcholine is such an important memory and cognitive brain neurotransmitter, but it’s also the main neurotransmitter. neurotransmitter for the vagus nerve and the lower esophageal sphincter.  So use that. Sometimes we’ll use phosphatidylcholine or other sources of choline as precursors for acetylcholine as long as well as the huperzine. So again, depending on the mechanism, I use different treatments. But I usually have people start out with the lifestyle issues. The Reduce Carbs, Reduce Reflux mnemonic, C A R B S, that has all those things in it.

Dr. Weitz: Is that, [01:03:00] so what kind of diet are you typically putting these patients on?

Dr. Sandberg-Lewis: Again, it depends. If they have SIBO, it’s going to be a low fermentation diet, right? If it’s, and most of the, again, when I came up with that mnemonic, Reduce Carbs, Reduce Reflux. The C A R B S was just a way to remember everything, but it is true that high carbohydrate diets seem to be the most important causes of reflux, and so most of the diets we use are lower fermentable carbohydrates, like FODMAP diet, or even Cedars Sinai diet, or Oh, Dr.

Dr. Weitz: White Rice, White Bread Diet.

Dr. Sandberg-Lewis: Hey, you know, it’s it’s the least restrictive. And so if you have a patient that just says, you’ve had these patients, they come in and say, okay, let me just tell you right at the start here, I’m not changing my diet. I don’t want to change my diet. [01:04:00] Or maybe they have an eating disorder, history of an eating disorder and you can’t really mess with their diet because they already have so many issues with it that they work with their counselor on.  So you want to, sometimes you use that as the least invasive as opposed to the biphasic diet by Dr. Jacobi, which is probably the most restrictive, but it works great and it’s great for vegetarians and vegans and low histamine also.  Right.  I have about five or six different diets I use depending on the situation, but I think the important thing is The meal spacing, going at least four hours between meals and 12 hours at least overnight and not eating at least for three or more hours before they go to bed.  That can be very important.

Dr. Weitz: Do you like adding digestive enzymes or herbal bitters to increase the likelihood that they’ll break [01:05:00] down the food?

Dr. Sandberg-Lewis: I think bitters are great for anybody that responds well to them. Bitter herbs, the bitter receptors are in most of the tissues in the body, even blood vessel walls, I believe.  We call them bitter taste receptors because that’s what we first discovered was they could taste bitters, but they do a whole lot of other really essential things. Yeah, bitters are great. Bitters are great. Digestive enzymes, I got a whole chapter on that because it’s pretty complicated, but certainly we treat people that don’t make enough pancreatic enzymes or don’t make enough brush border enzymes, but also, food based enzymes, raw food, sprouted food.  and the kind of plant enzymes that you can buy, they’re a whole different category, because they’re actually starting to digest food when it’s in the stomach, whereas most pancreatic enzymes that you produce in your own body, or [01:06:00] take as a a medicine that’s made from pork those only work in the small intestine.  So these plant enzymes are like food based enzymes that have a much wider range. Like I say, they start working in the stomach, they work in a very wide pH, instead of very narrow pH.

Dr. Weitz: So you like the plant based enzymes better?

Dr. Sandberg-Lewis: Well, they’re just a whole different animal. They’re not even an animal. They’re just, they’re so different.  Are they good? They can be extremely helpful. Okay. Yeah, even just, even papaya enzyme can be really helpful. protein. Yeah, for some people’s reflux can be really helpful. And it’s a helpful thing also for gastroparesis, which we haven’t talked about, but we nudged up against it when we were talking about ozempic.  But, you know, that’s another big one. If you have delayed gastric emptying, you have to treat that with a number of things that, besides prokinetic [01:07:00] herbs or drugs that help keep things moving through the stomach so they don’t back up into the esophagus.

Dr. Weitz: And delayed gastric emptying can be common in patients with diabetes and certain other conditions.

Dr. Sandberg-Lewis: Diabetes and celiac and other gluten intolerances I find are the biggest, biggest group that have that.

Dr. Weitz: So you use natural prokinetics or you use prescription prokinetics?

Dr. Sandberg-Lewis: Yeah, I’ll just mention too, traumatic brain injury is a major cause. Okay. Of delayed gastric emptying and gastroparesis as well, which is often ignored in medicine.  But yeah, I’ll I often, the simplest is ginger, right? Ginger is just a wonderful prokinetic for the stomach, upper GI, prokinetic. And that’s what, I think one of the reasons why it helps with, Nausea [01:08:00] in many cases. It also is a serotonin receptor modulator, which can help with nausea, but it’s, yeah it’s the simplest and most elegant if people tolerate it well.

Dr. Weitz: I think that’s the questions I had prepared. Any, anything else you want to tell us?

Dr. Sandberg-Lewis: I will tell you that there’s a chapter in the book called Your Brain May Be Sabotaging Your Digestion.

Dr. Weitz: Okay. Here’s the book right here. 

Dr. Sandberg-Lewis: It’s the only chapter I didn’t write.

Dr. Weitz: Oh, really?

Dr. Sandberg-Lewis:  It’s chapter 11.

Dr. Weitz: Okay. Who wrote that?

Dr. Sandberg-Lewis: My brilliant wife.

Dr. Weitz: Oh, okay.

Dr. Sandberg-Lewis: Kayla Sandberg Lewis wrote it. She’s a wife. Oh, okay.  biofeedback and stress management provider. And she, if you don’t read anything else in the book, I think that chapter really helps you get your lifestyle in gear, chewing, breathing,[01:09:00]  your approach to Eating, breathing, drinking liquids that can really provide the strong underpinnings for proper digestion.

Dr. Weitz: Chewing your food, eating slowly,

Dr. Sandberg-Lewis: drinking water away from meals in adequate amounts for hydration, together with breathing by using your diaphragm, like some of the things we alluded to, to get the vagus nerve working properly.  All these things are really important for vagal. function and just getting your body in the right neurologic phase for digestion.

Dr. Weitz: What about that heel drop exercise? I know we mentioned that last time we talked a year or so ago. That seems like a really cool exercise. Do you give that regularly to the patients?

Dr. Sandberg-Lewis: Yeah, I have a handout sheet [01:10:00] that we hiatal hernia too, but I have a little handout sheet when I do the visceral manipulation for hiatal hernia syndrome. I will give him that handout and it talks about avoiding breath holding during exertion and core muscle contraction. I teach people that before they get up off the table, I say, now take a nice full belly breath and breathe out as you sit up, as you contract your abdominal muscles.

So any exercises, core exercises they’re doing, anytime they’re lifting something heavy, or even more so, if they’re constipated, or even if they’re not constipated, if they bear down to have a bowel movement, and push it out, that’s okay, but take a full belly breath first and exhale slowly as you bear down, if you run out of air, stop bearing down, take another breath.

That way you’re reducing that [01:11:00] great increase in intra abdominal pressure that occurs when you hold your breath and do a Valsalva maneuver that greatly increases the intra abdominal pressure intends to push things upward. In addition, the heel drops exercise is just something you can do in the morning after a correction that we do in the office.  Drink at least 12 ounces of water to fill the stomach and weigh it down like a water balloon a little bit, and then go up on the balls of your feet, drop on your heels 11 times, and that, that pendulous stomach pulls down. And it helps to keep that correction that we did in the office in place below the diaphragm.

Dr. Weitz: Great. So everybody pick up Dr. Sandberg Lewis’s book and they can get a hold of you through your website. What’s your [01:12:00] website?

Dr. Sandberg-Lewis: HMM, which is Hive Mind Medicine, PDX, which is the abbreviation for Portland, dot com. HMMPDX. com.

Dr. Weitz: And you have courses available, correct?

Dr. Sandberg-Lewis: I teach courses and we have some online courses that we’ve done through Shivan Sarna and Neurala

Dr. Weitz: Jacoby.

Dr. Sandberg-Lewis: They have those at their websites.

Dr. Weitz: Yeah. I took the course that Neurala has on the physical. Yeah. That’s a good one.

Dr. Sandberg-Lewis: They did a really good job on that. They did a really good job on that.

Dr. Weitz:  Well, thank you so much, Stephen.


Thank you for making it all the way through this episode of the Rational Wellness Podcast.  For those of you who enjoy listening to the Rational Wellness Podcast, I would very much appreciate it if you could go to Apple Podcasts or Spotify and give us [01:13:00] a five star ratings and review. As you may know, I continue to accept a limited number of new patients per month for functional medicine. If you would like help overcoming a gut or other chronic health condition, and want to prevent chronic problems, and want to promote longevity, Please call my Santa Monica Weitz Sports Chiropractic and Nutrition office at 310-395-3111 and we can set you up for a consultation for functional medicine.  And I will talk to everybody next week.

Dr. Susan Sklar discusses Burning Mouth Syndrome with Dr. Ben Weitz.

[If you enjoy this podcast, please give us a rating and review on Apple Podcasts, so more people will find The Rational Wellness Podcast. Also check out the video version on my WeitzChiro YouTube page.]

Podcast Highlights

00:00 Introduction to Rational Wellness Podcast 
00:27 Understanding Burning Mouth Syndrome 
01:33 Dr. Susan Sklar’s Background and Expertise 
02:47 Personal Experiences with Burning Mouth Syndrome 
05:04 Exploring Functional Medicine and Hormone Therapy 
07:06 Challenges in Conventional Medical System 
09:56 Hormone Restoration and Neurosteroids 
16:44 Diagnosis and Treatment Approaches 
32:57 Diet and Lifestyle Considerations 
34:14 Final Thoughts and Resources


Dr. Susan Sklar is a Harvard-trained gynecologist who practiced medicine at her private practice in Southern California for 30 years, and now consults internationally through her official website SusanSklarMD.com.  Dr. Sklar pursued training in sexual function solutions for men and women and completed the nationally recognized fellowship in Anti-Aging and Regenerative Medicine sponsored by the American Academy of Anti-Aging Medicine. She is certified in the Bredesen Protocol for slowing and reversing early-stage Alzheimer’s disease and its precursor, mild cognitive impairment.  Dr. Sklar’s current professional specialty is the development of breakthrough treatments for Burning Mouth Syndrome, a chronic, neuropathic pain condition that affects primarily menopausal women. Hundreds of women have found relief in the hormone balancing protocols developed by Dr. Sklar in her practice.                               

Dr. Ben Weitz is available for Functional Nutrition consultations specializing in Functional Gastrointestinal Disorders like IBS/SIBO and Reflux and also Cardiometabolic Risk Factors like elevated lipids, high blood sugar, and high blood pressure.  Dr. Weitz has also successfully helped many patients with managing their weight and improving their athletic performance, as well as sports chiropractic work by calling his Santa Monica office 310-395-3111.

 



Podcast Transcript

Dr. Weitz:  Hey, this is Dr. Ben Weitz, host of the Rational Wellness Podcast. I talk to the leading health and nutrition experts and researchers in the field to bring you the latest in cutting edge health information. Subscribe to the Rational Wellness Podcast for weekly updates. And to learn more, check out my website, drweitz. com. Thanks for joining me and let’s jump into the podcast. Hello, Rational Wellness Podcasters. Today, we’ll be having a discussion with Dr. Susan Sklar about Burning Mouth Syndrome.

Burning Mouth Syndrome is a painful condition that causes a burning, scalding, or tingling sensation in the mouth. It can affect the tongue, lips, gums, inside of the cheeks, roof of the mouth or large areas of the whole mouth.  The burning can be severe, as if the mouth has been injured by a hot drink. Other symptoms include dry mouth or an altered taste in the mouth. Burning Mouth Syndrome can occur every day or may come and go. The symptoms can last for months or years. The majority of patients appear to be post menopausal women.  And while we don’t know what causes it, it may be related to hormones or to specific medications.

Dr. Susan Sklar is a Harvard trained gynecologist who practiced medicine at her private practice in Southern California. for 30 years. And now she consults internationally through her official website, SusanSklarMD.com. Dr. Sklar pursued training in sexual function solutions for men and women and [00:02:00] completed the nationally recognized fellowship in anti aging and regenerative medicine sponsored by A4M. She’s also certified in the Bredesen protocol for slowing and reversing Alzheimer’s disease. And Dr. Sklar’s current professional specialty is the development of breakthrough treatments for Burning Mouth Syndrome, a chronic neuropathic pain condition that affects primarily postmenopausal women, and hundreds of women have found relief And the Hormone Balancing Protocols developed by Dr. Sklar in her practice. So welcome, Dr. Sklar.

Dr. Sklar: Thank you. Yes, that’s all true.

Dr. Weitz: I realize I may have had some version of Burning Mouth Syndrome. I don’t know if this quite qualifies, but after the first time I had COVID I chewed some gum that had mint in it, and my tongue started burning, and every time I would eat anything that had mint or ginger, my tongue would burn.

Dr. Sklar: And then, did it resolve spontaneously?

Dr. Weitz: It lasted about two years, and then just went away.

Dr. Sklar: Whoa, so that’s very interesting. I’ve had people who I didn’t, but I’ve certainly run into people whose burning mouth, which they already had, got significantly worse with COVID. I also had one patient whose mouth pain went away when she got COVID because there’s a mechanism it’s with the mechanism, I don’t know if all of the iterations of COVID still have it, but the initial iteration of COVID, Remember, it could make people quite sick before they felt bad.

People would end up all of a sudden with their PO2s were, down in the [00:04:00] 70s and they had been feeling perfectly okay. So all the usual symptoms of discomfort, pain, air hunger, they didn’t have. And there is a particular mechanism that this woman’s immunologist thought came into play that actually had her burning mouth go away when she had COVID. And that was a couple of years ago. I have not been back in touch with her because she felt better and she, she didn’t need to see me anymore. But mostly the people I see, and it’s impressive that it lasted two years for you because that’s really a significantly long time.  And the actual definition is oral discomfort that lasts for longer than three months and occurs on a daily basis. 

Dr. Weitz: Now, it only occurred if I consumed something that had mint or if I ate ginger.

Dr. Sklar: That’s interesting. And mint is certainly an issue for people with burning mouth. Citrus is. It may be that you had a very mild version that only really [00:05:00] became noticeable when you had an irritant in your mouth.

Dr. Weitz: Yeah. Tell us about your personal health journey. And how you found your way to Functional Medicine and to Burning Mouth Syndrome?

Dr. Sklar: My personal health journey I, originally I was trained as an obstetrician gynecologist and then hence got into the whole field of men’s and women’s sexual medicine, which I did for a while.  And then, I had problems, oh, actually starting In my 30s and early 40s, GI problems and was diagnosed with colitis and put on any number of medications, including steroids, which made me crazy, like I would be up all night and only sleep for two hours a night and, Found myself in my bathroom cleaning the brass handles of the, of this thing at 3 am and saying, What the heck are you doing up at 3 a. m. with the, the brass polish? And never really got better. And [00:06:00] then it was actually an article in a local newspaper that talked about gluten. And everybody knows about gluten elimination now, but this was like, 35 years ago. And I thought, okay that’s not a hard thing to do.  I’ll just stop eating wheat and see what happens. And away went all of my colitis symptoms. And my GI doctor was like, because I had to go for regular colonoscopies and she, the nurses were surprised that I had a diagnosis of colitis and was not on any medication. And my GI doctor, I told her what I was doing and she said when I had my colonoscopy, so are you still doing that?

What diet was it you were doing? The thing with the gluten? And I said yeah. And that’s why I don’t have any symptoms or any lesions anymore. And so I could see the problem. And this is a, was a wonderful doctor, who was super caring. And I thought, Why wouldn’t somebody diagnosed, every time someone gets a [00:07:00] diagnosis of colitis or Crohn’s, why wouldn’t you give them a trial off of gluten and see what it does?  And so I began to see, personally how the conventional medical system fails people.

Dr. Weitz: And yeah, I was amazed over the years that the fact that on average, many gastroenterologists don’t think it matters at all what you eat. How could the study of the tube that the food goes down not matter what food you were putting in?

Dr. Sklar: Yeah, exactly Anyhow when that all was going on was around the same time. I was getting Burned out on OBGYN, dealing with insurance companies, quite frankly, and seeing, oh, 25 to 30 patients a day trying to relate to people in a 15 minute appointment. And I just thought, I can’t do this anymore.  I just, I’m [00:08:00] done. I can’t do it. And then I thought what else am I going to do? I’m not, like some doctors are like authors or there was this local dermatologist who made children’s clothes and she started a shop that carried children’s stuff. And I’m like, I’m not really equipped to do anything else.  That’s been my passion my whole life. So what am I going to do? We actually have a foster son that we took in, one of my kids friends in high school, and he said, I’ve been designing furniture, and I’m designing furniture for somebody who I think you’ll be interested in what she’s doing. She doesn’t want to say much of anything to me about it.

She’s very private about it, but I’ll see what I can find out. And it was somebody who ultimately ended up becoming a very good friend of mine who had been a plastic surgeon and got into the, quote, field of anti aging medicine and working with hormones. And she took me under her wing and, told me what courses to go to, and where to [00:09:00] study, and how to market, and really got me set up.

And so it turns out and it fits in very well, and I let all my gynecology patients know that I have this new practice. So a number of former gynecology patients came into my new functional medicine anti aging practice. Early on, somebody who actually hadn’t been one of my GYN patients, came to see me and I put her on the usual array of hormones for restoration.  Estrogen, Progesterone, Testosterone, DHEA, Pregnenolone, Melatonin, and Thyroid. And this woman happened to be a physical trainer. And she wrote a little testimonial that I put on my website. So this was in 2007. It was a rudimentary one page website. Nobody had blogs and stuff like that.  It was a single page my son set up for me. And she wrote this little testimonial that she said was okay to put on the website. And she said, Since in the two months that I’ve been on a [00:10:00] hormone restoration program, my energy is better, my mood is better, my muscle definition is better, and my burning mouth is not nearly as bad, which I honestly, I hate to say it, I didn’t really pay much attention to it because I kind of didn’t know what it was.

And people started approaching me saying, Oh, you treat burning mouth syndrome? And I was like well, not really. And so I spent an incredible amount of time in the neuroendoimmunology literature. Which is like brain research reviews and other journals trying to figure out what would a hormone have to do with a nerve pain or pain?  And it turns out, a lot. And in fact, these steroids are actually made in our nerves. They’re called Neurosteroids. When I saw the term Neurosteroids, I was like, Oh my goodness, I’ve hit the jackpot because this [00:11:00] explains what I’ve been seeing. 

Dr. Weitz: And repeat that one more time, what you just said?

Dr. Sklar:  There are steroid hormones like DHEA, pregnenolone and progesterone that are made in nerves and they are called neuro steroids.  There are neuroactive steroids, which are steroids made in other places, like the ovaries and the testes, that have actions on the nerves, but there are actually steroids made in these nerves. And they have actions on how nerves function. They’re anti inflammatory, they help nerve to nerve transmission.  And so the best I could figure out, because I didn’t know who to ask about this, was that, these hormones were somehow reducing inflammation and improving these people’s situation. It’s not a permanent fix, it doesn’t cure the situation, but it certainly gives people relief to the point where [00:12:00] They can, basically, it’s not ruling their lives and, you know, you’re a chiropractor, Ben.

You know what chronic pain does to people. For sure. It can destroy your life. It can destroy your relationships. Yes. And when it involves your mouth, it has to do with what you can or can’t eat. And so it ends up that people who have this isolate, don’t go out to dinner. A lot of our socializing is done over meals.

Right. Right. So that kind of goes by the wayside and a lot people’s gauge of how much better they are is what they can eat. Can they drink coffee now? Can they eat salads again? Can they socialize with friends like the one patient I mentioned who finally was able to go to Thanksgiving dinner with the rest of her family?

The other issue that comes up, am I still okay as far as freezing? Okay the other issue that comes up is, as you said, [00:13:00] A lot of the people that have this condition are perimenopausal and menopausal women. Our medical system really does not recognize a lot of what is going on with women as valid.  Thinks women are being hysterical, still. Think women are making it up that it’s in their heads. There are actually articles in the literature That says, Bernie Mouse Syndrome is because women are watching too many upsetting soap operas on TV.

Dr. Weitz: I saw that in one of your articles. It kind of reminds me of IBS, which is another, the most common gastrointestinal condition, which is more common in women, and was often dismissed as a psychological disorder.

Dr. Sklar: Right, exactly. So, women have that discrimination going on, not being believed, and you know, you talked about my website, the people with Burning Mouth Syndrome, of all of the patients I’ve ever met, with all their variety of medical are on the internet more than any other group of patients that I’ve ever encountered.  And it’s not unusual for somebody to tell me something like, yeah, I found you because I went to the Mayo Clinic, Oral Facial Pain Clinic, and they said, no, there’s nothing we can do for you. And I went home and I was crying all night and couldn’t sleep. So I got on my computer and I found you. And I hear that story over and over again.  People with burning mouth are on the computer incessantly.

Dr. Weitz: I was, I was looking around for some of the conventional medical perspectives on things and it looks like one of the most common treatments is to prescribe what you, which is sort of the cure all for almost any pain or neurological condition that they don’t know what else to do, they prescribe [00:15:00] gabapentin.

Dr. Sklar: Right.  Which seems to help a few people, and I, the problem with Gabapentin is side effects. So, people often feel zombie like on Gabapentin, too sedated to do anything. And so, I think there may be a place for it. By the time people come and see me, number one, if it was going to go away on its own, it already did.  If Gabapentin was going to take care of it, they don’t come and see me. But I’ve had people on gabapentin with side effects like sedation, who we’ve put on a hormone program, they feel somewhat better, but not all the way better, maybe, or they get all the way better, and we say, well, let’s try to withdraw the gabapentin so you don’t have so much sedation and problems from it, and they notice that their pain increases.

So sometimes it’s hard to, for people to tell if something’s working or not until you try to withdraw it. Right. So we try to use a low enough dose and other things to support them, but you’re right. Gabapentin, [00:16:00] also pregabalin or Lyrica is frequently used. The other thing that’s big in the literature for oral facial pain and trigeminal neuralgia is duloxetine.

And I have a long list of possible medications that I’m certainly happy to try people on. The problem with those medications is often they have side effects and, you know, what we know about hormone restoration is usually there can be some side effects, but usually there are side benefits. So people like the patient that I mentioned in the very beginning, who was kind of my start in burning mouth syndrome, her energy was better.  Her mood was better. So I see that people get those side benefits from being on hormones.

Dr. Weitz: So how do you diagnose patients with Burning Mouth Syndrome? Is this a purely clinical diagnosis, or are there some tests that can be done?

Dr. Sklar: It’s really clinical. It’s history. And like I said, by the time people see me, they’ve been [00:17:00] to multiple dentists, Ear, Nose, and Throat Doctors, Oral Facial Pain Clinic. So they’ve been examined and everything looks normal. Some of these people probably have small fiber neuropathy. And when I did a survey,

Dr. Weitz: what that is, Yeah,

Dr. Sklar: there are small nerve fibers that can degenerate and cause neuropathic pain. It could happen anywhere in the body and it can be you.  And it has a number of causes. Lyme can cause it. Mold can cause it. Viral illnesses can cause it. It can be an autoimmune reaction. And so very small

Dr. Weitz: Why would it be small nerve fibers?

Dr. Sklar: I don’t know if I have a good answer to you, but it’s the unmyelinated smallest nerve fibers that get affected.  That are sensory fibers. And you can make a diagnosis in a lot of cases by doing skin [00:18:00] biopsies because those small fibers penetrate the skin. And I suspect that in some people, of course, then you want to try to find the underlying cause because it doesn’t just go away on its own. If it’s Lyme, you want to treat the Lyme.  If it’s viruses, you want to treat the viruses. But doing a survey of my patients, about a quarter to a third of them have neuropathy in other places besides their mouth. So they may have peripheral neuropathy in their lower extremities. The patient that I mentioned that was my very first one who got better on hormones had burning on the skin of her shoulders on her back. Some people feel burning up into their nasal passages, down into the trachea and into the lungs and skin anywhere on their bodies. So we’re, I’m starting to look at, and everybody doesn’t get better on a hormone restoration program. The other things that have been brought up as potential contributors are mast cell activation, [00:19:00] Some Dr. Lawrence Afrin, who a lot of, of functional medicine know about in terms of mast cell expertise has a couple of papers out about putting people on histamine blockers like Pepsid, which, you’re not crazy about putting people on something like Pepsid, which is a stomach acid blocker long term, but if you’re talking about somebody not being able to live their life because of severe chronic pain, it’s a trade off.

And I’m using something like Zizol or Claritin or Zyrtex to for H1 blocking. So there seems to be, for some people, a mast cell component. And the more I go along, the more complicated the patients I see tend to be. And so I have a number of patients who have clearly mast cell overactivity, who’s, who get urticaria, hives, whose faces turn red at the, at the drop of a hat.  Who get itchy all over a couple of [00:20:00] people whose throat closes up and have to go to the ER as, a histamine reaction. So histamine and mast cells play a role for some people. The other thing that’s been posited as a possible cause is that this is a post viral, like post herpetic neuralgia.

And there’s a woman named Maria Nagel who’s in Colorado. She’s a neurologist, and she’s written a few papers on treating people with very high dose Valtrex or Valcyclovir. Right, so getting better on Valcyclovir, and it’s high dose for a prolonged period of time, like three to six months. Some people, it seems like, need to be on a maintenance dose long term.  But that has helped some people with burning mouth syndrome get better.

Dr. Weitz: Okay I also saw something about this condition called oral lichen sclerosis as being a cause, and it’s not [00:21:00] clear exactly what this condition is, and have you seen this condition as a factor?

Dr. Sklar: I haven’t I’ve seen more oral lichen planus and which is kind of flat, round lesions that occur in the mouth.  Okay. The lichen sclerosis not so clear about in the oral cavity. 

Dr. Weitz: Maybe it was planus. Yeah, I’m not sure.

Dr. Sklar: I’m very familiar with lichen sclerosis on the vulva having been an OBGYN, but yeah, I’ve certainly lichen planus in the mouth. That does not, I don’t see that very often. Okay.

Dr. Weitz: So are there labs that you run when you get these patients?

Dr. Sklar: Yes, there are labs I run. They don’t make a diagnosis of Burning Mouth Syndrome, but they help me rule things in and out. I do viral panels for varicella and herpes. It seems like a lot of these people have reactivated Epstein Barr virus, and I’m not [00:22:00] sure what role that plays in chronic pain.

Dr. Weitz: Right.

Dr. Sklar: There are a number of papers in the literature about micronutrient deficiencies and Burning Mouth syndrome.

Dr. Weitz: What’s your favorite, what’s your favorite viral panel that you like to run for clinicians out there?

Dr. Sklar: Usually I start with what people’s insurance will cover, so I will do Varicella, IgG, and IgM.

Dr. Weitz: Okay.

Dr. Sklar: Herpes type 1 and 2 IgG, Quest is no longer doing the IgM. I checked for Epstein Barr early antigen, as well as Epstein Barr VCA and eBNA.  Those are probably the main ones.

Dr. Weitz: Okay.

Dr. Sklar: Yeah. And I know there are some, good labs that do viral like Cyrix and or immunosciences, but

Dr. Weitz: Yeah. And Vibrain also has a viral panel.

Dr. Sklar: Right? Yeah. I haven’t used those. I mainly use Quest and LabCorp.

Dr. Weitz: Okay. [00:23:00]

Dr. Sklar: And then I check for micronutrient deficiencies.

Okay. So magnesium.

Dr. Weitz: How do you check for that? Do you run one of the micronutrient panels?

Dr. Sklar: No, again, I just use Quest and LabCorp, yeah, our Red Blood Cell Magnesium Copper and Zinc. CoQ10 levels

Dr. Weitz: Vitamin D, Omega 3. 

Dr. Sklar: Oh, definitely Vitamin D. I’ve had some people who got better, we did their labs, they were going to get their hormones.  Prescriptions and that sort of thing, but they went ahead and started on vitamin D because their vitamin D’s were incredibly low and their pain significantly improved. So definitely vitamin D is really important. I actually Probably an

Dr. Weitz: iron panel as well, right?

Dr. Sklar: We do iron, yep, ferritin. And then the other thing that can be helpful if this is central pain syndrome is low dose naltrexone.  So not so much in the talking more about treatment than lab testing.

Dr. Weitz: Tell us about low dose naltrexone for patients [00:24:00] and practitioners who are listening who are not familiar with it.

Dr. Sklar: So, low dose naltrexone, I was first introduced to for treatment of autoimmunity because it’s anti inflammatory.

Dr. Weitz: Right.

Dr. Sklar: And and it’s, and people, patients get freaked out. You have to explain to them what naltrexone is. And it doesn’t mean that they aren’t. Opioid addict but it is low dose of naltrexone and naltrexone for opiate addiction and reversal is treated at like 50 milligrams a pill. Low dose naltrexone is anywhere from 1.5 up to, I use a maximum of 9 milligrams. Some people use ultra low dose naltrexone, but I have less experience with that. And it’s been found to help central pain syndromes. Pain can live in your mouth, and if it’s a nerve in your mouth, if you inject local anesthesia into that nerve, It should relieve your pain [00:25:00] and numb your tongue.

The many of the, most of the people I see with burning mouth syndrome, if you do that, they would still have their pain because their pain now lives in the brain, not only in their tongue. And so for those central pain syndromes, low dose naltrexone helps the release of our natural. opioids that our body can produce.

So our natural endorphins and opioids and help with reducing pain. So I usually start people on a hormone restoration program. We see how it goes for a month or so. If things start getting better, great. If not, we add low dose naltrexone, and also at the same time I’m correcting iron deficiency or magnesium co Q10, all the micronutrients and vitamin D at the same time.

Dr. Weitz: So tell us about your hormone restoration program. Do you, how do you test the hormones? How do you prescribe and [00:26:00] how much in general are typical treatment protocols for you?

Dr. Sklar: Again, I use the regular commercial labs and test estradiol, progesterone, testosterone free and total thyroid 3T3, 3T4, and thyroid stimulating hormone and DHEA and pregnenolone.  And I try to have treatment levels, after treatment. in the range of a young adult. So I try to have estrogen levels between 60 and 80, maybe not as high as the young menstruating women, but I don’t want it in the hundreds for postmenopausal women. Progesterone between 10 and 20, which is the luteal phase optimal level at ovulation, or rather 14, like five to seven days after ovulation.  DHEA, I try to put pretty high a lot of us in functional medicine use pretty high [00:27:00] amounts of DHEA and don’t feel like there’s really an upper limit. In terms

Dr. Weitz: Give us an idea of what Of dosing. Level of dosing of supplements and then what level on the blood do you like to see?

Dr. Sklar: Right.  So for estrogen, I usually have people use an estradiol patch. Okay. And they use anywhere from 0. 025 to usually 0. 5 is, 0. 05 is enough in a bi weekly patch progesterone people are on 100 to 200 milligrams of micronized oral estrogen, which I like to use because one of the things that oral estrogen does is get metabolized to something called allopregnanolone.  And allopregnolone is a really potent, calming, anti inflammatory, neurosteroid, neuroactive steroid.

Dr. Weitz: Oral progesterone, right?

Dr. Sklar: Oral, so topical progesterone does not go through that conversion. Into allopregnolone. So I intentionally will use oral progesterone. [00:28:00] And there’s debates about all of this in the, I think

Dr. Weitz: it’s pretty typical for a lot in the functional medicine community to use a topical estrogen and an oral progesterone.

Dr. Sklar: Okay. Yeah. I was just listening to a talk by an expert who said don’t use oral progesterone. It goes through bad metabolism in the liver. And I was like, I don’t agree with that. We use DHEA and usually for women, it’s anywhere from 25 to 50 milligrams a day. For men 50 maybe to 100 Pregnenolone, and I see some people with like incredible low DHEA and Pregnenolone levels anywhere from 50 to 100 milligrams of Pregnenolone in a day.

Okay. Thyroid, I like to have people’s T3 in the upper quartile of normal, so if your reference range is 2. 3 to 4. 2, have it [00:29:00] somewhere 3. 5 to 4. 2. And testosterone for women to see, again, at the upper end of the normal range. For women, it’s somewhere around 35 to 45. For total testosterone.  And so the dose of testosterone I’ll use is somewhere anywhere from, oh, one to up to five milligrams a day, mostly around 2. 5 milligrams a day in a topical cream.

Dr. Weitz: Are there some women that you will not recommend hormones for?

Dr. Sklar: Yes. I had one patient who has I’m trying to remember, it wasn’t factor V Leiden, but she had a blood clotting diathesis and her hematologist said no hormones whatsoever.  And we did everything else, put her on low dose naltrexone, corrected all the micronutrients. He did let her be on vitamin D and her pain improved significantly. Women who have had breast [00:30:00] cancer, I have them check with their oncologist. Some oncologists are okay with women using not estrogen necessarily, but DHEA and pregnenolone, they’re not so worried about the downstream effects.  So I would say those are the two main classes of people in whom I would not use hormones and of course men who have had prostate cancer.

Dr. Weitz: I guess there’s certain medications that can trigger burning mouth as well.

Dr. Sklar: There are. There are certain anti hypertense drugs. Antihypertensive, like the angiotensin receptor blockers. I’m always trying to have people do a trial off of those. I haven’t really found that to be a big contributor, I must say.  That, that hasn’t panned out to provide people with a whole lot of relief. Quite honestly. Okay,

Dr. Weitz: so even though maybe they triggered it, they take him off, it doesn’t make it go away.

Dr. Sklar: It doesn’t seem like it, no.

Dr. Weitz: Okay, so [00:31:00] what percentage of the patients that you’re treating for Bernie Mouth get a fair amount of relief?

Dr. Sklar: Yeah, so somewhere around probably 60 to 65% which may not sound real high, but you’ve got to realize these are people that have been everywhere to all the major pain clinics and then I realized there were people that would not be able to come and actually become a patient, and so I developed a supplement called BMS Advanced Support Burning Mouth Syndrome.  We abbreviate BMS and I put DHEA and pregnenolone in it. Oh, B12, I forgot to mention, but certainly B12 is really important for nerve function. So it has methylfolate in it. And And Lipoic Acid because there’s some literature that shows that Lipoic Acid helps neuropathic pain. And I put it together in a supplement and it turns out it’s not effective for everybody, but about 25 or 30 percent of people get [00:32:00] really dramatic relief of their burning mouth and have just ordered it for years.  If you’re one of those people, it ends up really good for you. So that is available for people who are not going to actually become patients of mine.

Dr. Weitz: What’s your guess how many people out there are suffering with this condition?

Dr. Sklar: So there are really wide estimates, but probably millions.  I hear from people all over the world. I have a course for patients, takes people through, takes the public through the different kinds of things that might be, it might be a virus, it might be this, it might be that, what the conventional system, how it evaluates you, how to find a practitioner that might know something about hormone restoration.  And we had people from Australia and a whole variety of places. I hear from people in Europe fairly often about wanting to order a supplement. I do hear from people all over the place.

Dr. Weitz: Does diet play a [00:33:00] role?

Dr. Sklar: For some people it does. I encourage people to do a gluten free diet and a sugar elimination.  And that has made a dramatic difference for some people.

Dr. Weitz: So sugar elimination, you mean like gradually eliminating sugar or just stop?

Dr. Sklar: If you can just stop it, sugar is really inflammatory. Absolutely. Yeah, so I try to get people just to stop cold turkey. Yeah, I

Dr. Weitz: have a lot of patients. Gluten, Dairy, Sugar, just take it out right away.

Dr. Sklar: So one of the problems with these patients is their nutrition, because a lot of times they end up all they can eat is like rice and oatmeal. And so they become very nutritionally deprived. And so I try not to, I’m not sure how much dairy plays a role. So if they can eat yogurt because it’s smooth and it’s cool.  I try not to eliminate that, but gluten certainly seems to be a big one. And then people will [00:34:00] naturally, like I said, not eat oranges and grapefruit and spicy foods because it’s just too painful.

Dr. Weitz: That’s great. Those are the questions that I had prepared. Anything else you want to tell us about this condition and to help give some hope to people out there who are dealing with it?

Dr. Sklar: Yeah, absolutely. And I really appreciate this opportunity, Ben.  So often people are made to feel like it’s in their head and it’s not in your head. If you feel pain, You need to pursue it until you find somebody who can help you and take you seriously, because that’s the most heartbreaking part of it.  I’ve had patients who were admitted to mental institutions because their doctors thought they were that crazy. And yeah, it’s, it can get really extreme. You really need to pursue care until you find somebody who [00:35:00] believes you, and at least can start. looking into treatment and help for you.

Dr. Weitz: How can those listening or viewing get a hold of you and find out how you can help them?

Dr. Sklar: Yeah. I have a new website called www. susansklarmd. com. Okay. I recently sold my functional medicine practice. So there is still a Sklar Center website. But that’s no longer the Burning Mouth website.

Dr. Weitz:  Interesting.

Dr. Sklar:  Yes. So my new website is called Dr. Susan Sklar’s Hope for Burning Mouth. Okay. And so www. SusanSklarMD. com will take you to the website. I also have a Hope for Burning Mouth YouTube channel that has a ton of videos and a lot of information.

Dr. Weitz: And you mentioned you have a training program as well.[00:36:00]

Dr. Sklar: I have on my website, people can sign up for an educational program. It’s got 12 modules. It’s very detailed and has references and can help direct people to try to figure out how they can get help. And I’m working on a course.

Dr. Weitz: patients or practitioners?

Dr. Sklar: I’m sorry, what did you say?

Dr. Weitz: Oh is that for patients or practitioners?

Dr. Sklar: So that’s for patients. Okay. And I have a partially done course for practitioners. Oh. Yeah, so all the detailed research and papers I just filed away because someday there’s going to be a practitioner’s course.

Dr. Weitz: Okay. That’s great. Thank you so much, Susan.

Dr. Sklar: You’re so welcome. Thank you for having me.


Dr. Weitz: Thank you for making it all the way through this episode of the Rational Wellness Podcast. For those of you who enjoy listening to the Rational Wellness Podcast, I would very much appreciate it if you could go to Apple Podcasts or Spotify and give us a five star ratings and review.  As you may know, I continue to accept a limited number of new patients per month for functional medicine. If you would help overcoming a gut or other chronic health condition and want to prevent chronic problems and want to promote longevity, please call my Santa Monica Weitz Sports Chiropractic and Nutrition office at 310-395-3111.  And we can set you up for a consultation for functional medicine. And I will talk to everybody next week.

Dr. Ben Weitz discusses Coronary Artery Disease at the Functional Medicine Discussion Group meeting on August 22, 2024.  This was the first annual Dr. Howard Elkin Memorial Integrative Cardiology Lecture.

[If you enjoy this podcast, please give us a rating and review on Apple Podcasts, so more people will find The Rational Wellness Podcast. Also check out the video version on my WeitzChiro YouTube page.] 

 

Podcast Highlights

4:32  The goals of this presentation are:

1. To help you understand more about what coronary artery disease is, how plaque forms, and what happens when you have a myocardial infarction, or heart attack. 

2. Is to understand advanced lipid testing and direct testing of the arteries, including the CT Angiogram with Artificial Intelligence. 

3. To understand how to treat coronary artery disease, with an emphasis on diet and nutritional supplements.

5:22  Heart disease continues to be the Number One killer in the US and coronary artery disease continues to be the number one form of heart disease. Over 800,000 people in the US suffer a heart attack every year.  Coronary artery disease refers to disease in the arteries that supply the heart.  The most important artery is the Left Anterior Descending Artery, which supplies over half of the heart muscle with blood and oxygen. The LAD is also known as the “Widow Maker”, because if this artery becomes clogged by a heart attack, you will most likely die.

6:36  Plaque and Plaque rupture.  What happens in coronary artery disease is that the arteries become lined with plaque and this plaque is composed of oxidized plaque, as well as inflammatory and white blood cells. The inside of the arteries is called the endothelium and this is a crucial surface. If the endothelium is not functioning properly, we refer to this as endothelial dysfunction, and this can result in decreased production of nitric oxide production.  Lining the surface of the endothelium are the finger like projections known as the glycocalyx, which is composed of glycoproteins and proteoglycans.  What usually leads to a heart attack is not that the arteries become more and more closed up, but most of the time what happens is that the plaque ruptures, forming a clot, which occludes the coronary artery.  By the way, plaque that is calcified is usually more stable and less likely to rupture.  In order for plaque to form, you need to not only have cholesterol, but also oxidation or inflammation, so on labs you want to look at measures of oxidation and inflammation.

14:50  Other Risk Factors.  One risk factor for CAD is uric acid, which is not just a marker for gout but is a marker of metabolic disease, which Dr. David Perlmutter has pointed out to us. Over 5.5 is considered elevated for metabolic disease. Fibrinogen is a marker for clotting.  Elevated iron and ferritin increases the risk for clotting.  Lack of sleep, lack of exercise, and stress also increase risk. Elevated Homocysteine is an inflammatory marker in the blood stream separate from cholesterol that increases your risk of heart attack and stroke.  According to Dr. Houston, the risk starts when homocysteine if above 5 and really increases exponentially when it is above 12.  The way to lower homocysteine is with methylated B vitamins and trimethylglycine.  Low and high thyroid both increase the risk for heart disease.  Micronutrient deficiencies.

23:11 The Advanced Lipid Profile.  There are a number of specialty labs that offer Advanced Lipid Profiles, including Boston Heart and Cleveland Heart, both of which Dr. Elkin often ran. The advanced lipid profile looks at not just LDL but also LDL particle number and particle size.  It’s the small, dense LDL that puts you at the biggest risk. Another marker that has recently become more popular is ApoB, which is Dr. Peter Attia’s favorite marker.  I will show you an example of a patient who had normal ApoB but many other risk factors, such as small, dense LDL and inflammatory markers. I am arguing that there is not one best marker for Coronary Artery Disease but rather we need to look at the full picture that includes a number of markers.  Other tests that you want to look at are Oxidized LDL, Lp-PLAC, and MPO, all of which are markers for inflammation in the arteries.  This profile should also include Lp(a), which is a particularly atherogenic LDL particle, often described as sticky. Other markers that are often included are Vitamin D, Omega 3, CoQ10, ADMA, and TMAO.

 

 



Dr. Ben Weitz is available for Functional Nutrition consultations specializing in Functional Gastrointestinal Disorders like IBS/SIBO and Reflux and also Cardiometabolic Risk Factors like elevated lipids, high blood sugar, and high blood pressure.  Dr. Weitz has also successfully helped many patients with managing their weight and improving their athletic performance, as well as sports chiropractic work by calling his Santa Monica office 310-395-3111.

 



Podcast Transcript

Dr. Weitz:  Hey, this is Dr. Ben Weitz, host of the Rational Wellness Podcast. I talk to the leading health and nutrition experts and researchers in the field to bring you the latest in cutting edge health information. Subscribe to the Rational Wellness Podcast for weekly updates and to learn more, check out my website, drweitz.com. Thanks for joining me and let’s jump into the podcast. Thank you everybody for attending a Functional Medicine Discussion Group of Santa Monica. And our next month we have Dr. Tom O’Brien who will be speaking on Tuesday the 24th, so that should be really exciting. He’s a great speaker he’s spoken with us before, he has a new presentation he wants to talk about so definitely put that on your calendar.


Integrative Therapeutics is our sponsor for this evening. So I want to thank them for sponsoring another one of our meetings. And if you’re not familiar with their products, they’re one of the few professional lines of supplements that we carry in our office. And they have a number of great products for every condition, including cardiovascular.  We use their berberine regularly. They have several highly advanced forms of curcumin, Their latest one is Curalieve and it’s super highly absorbable. So that’s a great product at one capsule twice a day is easy to take. It’s super effective. Lowering inflammation.


I want to say tonight there’s some good news and there’s some bad news.  So the good news has to do with me. I don’t know if everybody’s aware, but I fell and fractured my femur on Halloween night and had surgery the next day. And unfortunately it wasn’t healing because there was a gap between the bones after the surgery. And so it was diagnosed as a non union, but I can now say that it has healed.  The mic’s not working? Okay. I’ve got to keep my mic on. Keep it close to my mouth. Okay. Thank you, Bernie. I’ll just repeat the good news is that it’s about me. I fell and fractured my femur, and it wasn’t healing. I have a non union. And I was told I needed another surgery, but in the functional medicine world, we believe in the ability of the body to heal itself.  And so I wasn’t going to accept that. So I came up with a plan. I scoured research showing that a drug called Forteo, which simulates new bone cells helps healing of non-union fractures. And I started taking injections of Forteo, I also used Human Growth Hormone two IUs a day, and I started using a bone stimulator, and I did that for four months, along with, of course, all the supplements, 10,000 IUs, Vitamin D, 45mg MK4, Boron, Calcium, Magnesium, Strontium, Collagen, Glucosamine and I can now say that my hip is healed.  Yay! So, thank you. I’m really happy.

The bad news is that our friend and colleague, Dr. Howard Elkin unfortunately passed away on August 1st.  He used to come to our meetings regularly, he worked at my office one day a week for about a year. He was a great integrative cardiologist.  He also did prescribe bioidentical hormones and trying to find another cardiologist to send his patients.  There was nobody like Howard. So very sad. So I’m dedicating this talk to Howard Elkin. So this is the first annual Howard, Dr. Howard Elkin Memorial Talk on Integrative Cardiology. So let’s get started here. This is Howard’s book.

And so the goals of the presentation are number one to get you to understand more about what is coronary artery disease, how does plaque form, and what happens when you have a myocardial infarction.  Number two is to understand the testing and in particular, advanced lipid testing. And we’re also going to talk about some of the direct testing.  We have somebody from Cleerly Health to talk about the CT Angiogram with Artificial Intelligence, which is the latest test that allows you non-invasively to see exactly what’s happening inside the arteries.  And then I’m going to focus on some of the approaches to treating coronary artery disease with an emphasis on diet and supplements.

So heart disease continues to be the number one killer in the United States and coronary artery disease is the number one cause of heart disease. Over 800,000 people in the U.S. suffer a heart attack every year. And heart disease is still the number one killer in women as well.  It’s common for women to be fearful about breast cancer, but the number of women that die from breast cancer on average is a fraction of the number of women who die from cardiovascular disease.  So, that should be the focus for preventative medicine.

Coronary artery disease has to do with disease in the arteries that supply the heart and these are four of the main arteries that supply the heart. And this artery right there is the Left Anterior Descending artery. And that artery supplies over half of the heart muscle.  And if that artery becomes completely clogged by a heart attack, you’re most likely not going to make it. They call that the widow maker. Alright. So, what happens in coronary artery disease is that the arteries become lined with plaque and plaque is composed partially of oxidized cholesterol, as well as inflammatory cells, white blood cells, etc.

But what usually leads to a heart attack or a myocardial infarction is not that the arteries become more and more closed until they’re fully closed. 75 percent of the time what happens is that the plaque ruptures, it breaks open and forms a clot. And so the mere presence of cholesterol does not mean that you’re going to have plaque buildup.  The most significant factor is that the plaque becomes oxidized and or inflamed. So looking at markers of oxidation and inflammation are super important.

So let’s see, the endothelial lining of the arteries. So the inside of the arteries is called the endothelium. And we think that is where a lot of the action happens. And there’s a lot of focus in the research on the health of the endothelium. And there’s several things. [Hey, Johnny.] There’s a number of things we can do to improve the health of the endothelium.

Okay, so here is a slide about the endothelium. So the endothelium is this one, [Hi Roxane], is this one cell lining of the inside of the arteries. And if the endothelium is not working properly, we call that endothelial dysfunction. And what that will mean is that typically you’ll get less nitric oxide production.  Nitric Oxide is one of the key players in heart disease. Having good Nitric Oxide production reduces hypertension, improves the health of the arteries, and it’s super important. And here’s a finger-like lining of the endothelium, those little finger-like projections. That’s called the glycocalyx. The glycocalyx is composed of glycoproteins and proteoglycans.  And the health of the glycocalyx is super important in understanding what’s going on.

So, here’s an example of plaque inside the arteries. And so on the left side we have you see the plaque and if the plaque rushes, it looks something like that, and this is where you have a calcium fibrous cap like a [00:09:00] plaque. And so, most people are concerned about having calcium in the arteries.  It turns out that if you have plaque in your arteries, it’s bad. If that plaque is covered by calcium, it’s more likely to be stable, and stable plaque is less likely to lead to a myocardial infarction. So I have a short video here, just in case you don’t understand this. The heart pumps blood to the body through a complex network of arteries.

With the exception of the coronary arteries, which nourish the heart itself, most arteries transport oxygen rich blood away from the heart.  Let’s see. 1, Cancer, 2, and 0. I’d be like, what’s happening to me? It’s a tragedy. Trouble? Wait a minute. What do you think the sound holds up to? The heart pumps blood to the body through a complex network of [00:10:00] arteries.


Let’s take a turn. Circulating in the blood are red blood cells, white blood cells, nutrients, and other life sustaining substances. Cholesterol and other fatty substances also circulate in the blood. Over time, these substances can be deposited in the artery walls, a condition called atherosclerosis. The deposited cholesterol, or plaque, can build up over time, causing hardening and narrowing of the otherwise smooth [00:11:00] artery walls.

When the walls of the artery become narrowed and hardened, blood flow is restricted. As the plaque accumulates, the buildup can become unstable and may break off or rupture. A condition called thrombosis results when blood starts to coagulate or clump together at the site of the rupture, similar to the way blood clots to stop bleeding from a pipe.

A blockage or thrombus can grow larger, further restricting the flow of blood. The thrombus is also in danger of breaking from the site and traveling through the arteries. The blockage caused by a thrombus can be life threatening. A blockage in the coronary arteries may cause a heart attack. While a blockage in a cerebral artery may cause a stroke.

Blockage in one of the major arteries of the body can prevent blood flow to an extremity or organ. Causing pain and tissue damage to the area.[00:12:00]


Great. That was pretty interesting.  So, in order to control inflammation and oxidation, this is a list of supplements from Dr. Mark Houston’s book.  By the way, this is one of the best books about coronary artery disease. I don’t know if you know Dr. Mark Houston, but I’ve studied a bunch with him, and he is one of the premier teachers of cardiovascular medicine.  He teaches for A4M.  This [book] is called The Truth About Heart Disease. But, yeah, this is all about coronary artery disease. There’s actually a lot of supplements, I probably take almost all of them, and here’s a list of the top anti oxidant foods I could go through all of those.

Okay, so Yeah. Okay, so the top list that I choose, these are the examples for someone familiar with Can you just hold that for a second? [00:13:00] Oh yeah, sure. There you go. And human stuff. Sorry. Annatto.  Yeah, it’s interesting how beans are so high in antioxidant. Beans are really super healthy, even though Dr. Gundry says they’re not.

As long as they’re properly cooked, and if you undercook your beans, you’ll know it. So, high blood pressure, obviously it’s a super risk factor for coronary heart disease. Smoking, everybody knows about. Cholesterol, dyslipidemia, insulin resistance, diabetes. If you have diabetes, you have three times the risk of heart attack.  I’m going to focus more and just talk about some of the other factors, but diabetes is super important. Insulin resistance, it’s in the stages of a heart attack. [00:14:00] Needs to be addressed. This is about inactivity and obesity.

Now, this is a list that not everybody thinks about, so I’m going to spend a little more time on this.  So, uric acid is a very important marker. Significantly increases risk of coronary artery disease. It’s typically not measured by most doctors. We do it.  I run a lot of panels to Vibrant America, and we always look at uric acid. Dr. David Perlmutter has really emphasized the importance of uric acid as a metabolic marker and not just as a marker for gout.  We have fibrinogen, fibrinogen is an important marker to look at, increases risk of clotting, the blood gets thicker, that increases your risk.  Elevated iron and ferritin.  I did a podcast with a doctor from, wrote a book about Hemachromatosis, and 30% of population has at least one gene that makes them more likely to store iron.  But guess what?  We have no idea because iron doesn’t get measured on most patients. I had a patient who was being treated for anemia was because their, he, because their hematocrit and their hemoglobin were high [meant to say low]. And they put him on iron.  Nobody ever measured the iron. He doesn’t need iron.  He was having a problem. He’s a painter. He was having a problem with lead toxicity, which was blocking his iron. So giving him more iron was never going to fix it.

I had a couple of women, a mother and a daughter, they’re both vegan, they have high iron and ferritin but nobody measured it.  They’re vegan, everybody assumed that they needed iron, but they’re storing iron, so start measuring iron, do a whole iron panel on all your patients, you’re going to find a number of patients that need to reduce their iron, and here’s some strategies for reducing the iron. For one thing, high dose curcumin, there’s a number of things you can do.

Sleep, is super important.

Homocysteine. How many industry measure homocysteine? Okay. Homocysteine is a inflammatory marker in blood, separate from cholesterol. It significantly increases your risk of heart disease. According to Dr. Houston, risk starts when homocysteine is above 5.  Yes, most of the labs say it should be under 12. Now, after 12, it really shoots up. We usually try to get it below 8. Getting it down to 5 is hard, but it’s interesting. So, homocysteine is super important. The way you get it down is with specific B vitamins.

For Thyroid anything that causes inflammation, I put low hormones because we know that having proper good levels of hormones is super important for health.  Anything that causes inflammation such as chronic infections, toxins mold, it turns out [00:17:00] that Dr. Elkin, the day he was moving out of his house because he had mold. Addisalice, so that could be an inflammatory trigger micronutrient deficiencies, gut health, Dr. Elkin regularly ran stool tests on his cardiovascular patients, everybody thought he was crazy, but it’s super important, we all know, especially in functional medicine, it all starts in the gut.

Alright, so the controversy about cholesterol, and we have Johnny Bowden in the back of the room who wrote The Great Cholesterol Myth. And so, it’s a question whether cholesterol itself is a factor. Most of the studies indicate that it’s only when cholesterol becomes oxidized or when there’s inflammation in the arteries that cholesterol really becomes a problem.

Cholesterol is essential for all these functions in the body. It’s essential for producing. Our sex hormones, it’s important for brain health there’s a whole series of nutrients that won’t get produced, you don’t have sufficient levels of cholesterol, it’s how our body makes vitamin D from the sun it’s no wonder patients in Southern California, I, we measure vitamin D all the time, it’s amazing how many people come in who get plenty of sun and they still have low vitamin D. And one of the reasons could be because everybody’s trying to get their cholesterol down so much.

So, oxidation, inflammation interestingly, just to throw something into controversy, and I’m not going to make any conclusions about it, but, we debate what should be the best level of LDL cholesterol, and we’re going to talk about my LDL is.  itself, not necessarily the best marker, but there was a study done recently, University of Pittsburgh, and they found that the patients who are least likely to die of heart disease had LDL [00:19:00] cholesterol in a range of, while it was long term, it was 20 or more, not just heart disease. They had cut LDLC in the range of 100 to 189.  So, there’s still things we probably don’t know about this whole situation. Yeah. Bernie . I was going into small . Yes, absolutely. Which is rich. Oh, the small particle is the one you have to worry about. I mean, is that Bridge point to C. Okay. So, we’re gonna talk about this, but the most doctors, most cardiologists run what’s called the Basic Lipid Profile.

And that means total cholesterol, estimated LDL, what they call LDL C. They just go, it’s about this much LDL. They don’t count the particles of HDL and triglycerides. And it’s wonderfully inadequate. [00:20:00] It’s really malpractice that they’re not running a advanced lipid profile, and that’s where we can come in as functional medicine practitioners.

And, in fact, if you start running the advanced lipid profiles, and we’ll talk about that soon, as well as some of the other advanced steps I have a good relationship with my primary care doctor, and sometimes we run these advanced lipids on his patients, and I share the information with him. I help the patients with the nutritional approach, but Sure.  He can’t run those panels because the insurance companies come after him. And, I know it’s criminal. It’s crazy that we let insurance companies run our health care system. It’s really not good for us. So, you can run these advanced lipid panels and you’ll save the patients money. Because if they get sent on insurance to run an advanced lipid profile and it’s not covered, they’ll get charged thousands of dollars.[00:21:00]

Whereas we can get a really good advanced lipid profile for you. We use Vibrant America and so we can do advanced lipids, hormones, thyroid nutrients and get it done for four or five hundred dollars. Okay. So we just talked about the basic lipid profile and even cardiologists are not running it even though they should and the reason why is insurance coverage and time.  So they just run the basic lipid profile.

Okay, so what is the Advanced Lipid Profile? Well, there’s a number of specialty labs that offer Advanced Lipid Profiles. Howard, Dr. Elkin, he often ran either Boston Heart or Cleveland Heart. And all of these labs have special parts of their tests that the other labs don’t have.  They’ve developed a proprietary testing. I’ll [00:22:00] show you a few examples of Advanced Lipid Profiles so you can get a better idea of how to interpret some of these. All right. So the Advanced Lipid Profile typically will look at not just LDL, not just total cholesterol and estimated LDL, but it’s going to look at LDL particle number and particle sizeSo it’s the small dense LDL that puts you at biggest risk. Lately, a marker that has become more popular is ApoB. Peter Attia says it’s the only one you need to look at and it’ll determine your risk. I’m going to show you a slide later on, on somebody that Howard tested who had a Cleveland Heart Lab, had totally normal ApoB, but is at a lot of risk, because they had a lot of small dense LDL, and other inflammatory markers.  So, I’m going to basically be arguing that there’s not one marker that’s best. We need to look at a number of markers. Other tests that you want to look at, Oxidized LDL, Lp-PLAC, and MPO. Those are all markers for inflammation inside the arteries. So inflammation is the key, as we know there’s so many different diseases, and it’s certainly the case with Coronary artery disease.

Lp(a).  How many of you test for Lp(a)?  Everybody should be getting testing for Lp, little a. I’ve had arguments with primary care doctors. No, it’s hereditary. You can test for it while they’re in the process of developing drugs for Lp(a). And once those drugs are out in a few years, everybody’s going to test for it.  But now, they don’t want to test for it because they don’t know what they can do about it. But there are things that we could do, and we’ll talk about that. Vitamin D, Omega 3 is super important, Coenzyme Q10, ADMA is a marker for nitric oxide status. Not everybody [00:24:00] offers that. Unfortunately, Vibrant doesn’t offer it.

TMAO is a controversial marker. I don’t share anything about that. There’s this doctor at Cleveland Clinic, Stanley Hazen. It just seems like every six months he comes out with some other study, trying to tell us that everything we, we think is good is actually bad. And so, TMAO is this marker that’s supposedly correlated with heart disease.  Do you know what the biggest source of TMAO is? Fish. We know how important fish is for health. TMAO is formed from either L carnitine or choline. So it recommends not eating foods that have choline or L carnitine. Do you know how important L carnitine is for the heart? Do you know how important choline is for the brain?  So, I’m very skeptical of TMAO as a marker, but there’s something to it.

Okay genetics, I’m not really going to comment about this. This is a panel that Dr. Mark Houston developed with Vibrant America, and these are all, you can get this whole panel done from Vibrant. These are important markers, so you see ApoE, you’ve probably heard of ApoE3, ApoE4, that’s a risk for Alzheimer’s, but also for cardiovascular disease.

Alright, Lp little a. Lp little a is a particularly atherogenic, sticky LDL particles, It’s super important. It puts you at higher risk for heart disease. The trainer from The Biggest Loser, he had a massive heart attack and this was his only risk factor that they could find.  So, if you have elevated levels of Lp(a) above 30, especially above 50, you definitely have to address it. So it’s important to know that. What can you do about Lp(a)?  Statins actually raise Lp(a). This is more common in African Americans. PCSK9 inhibitors, these are injectable drugs that lower cholesterol, and they can lower Lp(a) 20-30%.  Like niacin, it’s very effective at lowering Lp(a) 20-30%.  So we use a controllable release of niacin and niacin has fallen out of favor from doctors because of some, quite frankly, bad studies, but niacin is very effective when used in proper dosages as part of a nutritional program and I’ve seen patients where their Lp(a) will drop 50 percent just with niacin.  L-Carnitine, 10-20 percent reduction in Lp(a), CoEnzymeQ10 can help, Ground Flaxseeds.  Then there’s this Linus Pauling strategy. We don’t know, I don’t think there’s any human studies, I think it comes from animal studies, but this Progeny of Dr. Pauling, somehow it came out of his research on vitamin C, the combination of vitamin C, Proline, and Lysine, and he had an Lp one way for binding to the artery walls where it don’t qualify.  So that’s another strategy. Dr. Joel Kahn, I don’t know if you’re familiar with him, he’s an integrative cardiologist in Michigan. He wrote a whole book about Lp(a). I did an interview with him, so you can check out my interview with Dr. Kahn on my podcast, Rational Wellness. Oh, Dr. Joel Kahn, KAHN. He has a weekly podcast, truly good.

Homocysteine, you mentioned Homocysteine. There’s fundamentals of B vitamins, they exclude ethylated B vitamins and trimethylglycine can lower hopelessness in most patients by emptying. [00:28:00] You might have to use two or three capsules a day, but just keep experimenting.  You can usually get it down. Sometimes adding extra TMG, Trimethylglycine, can be beneficial if it doesn’t come down to split the B vitamins. Oh, a lot of the companies have formulas specifically related to this. ApoB testing, so Peter Attia says this is all you need. There’s one ApoB particle for every LDL particle.

Wait, go back one sec. Yeah, sorry. Sorry. You know what, I’m happy to share my slides with everybody. Great. Yeah. Yeah. Absolutely. Uh, so, we talked about LDL particle number, that’s the LDLp, that’s where they actually count the number of LDL particles, as opposed to estimating it, [00:29:00] and it’s the small dense LDL particles that are more likely to penetrate through the wall of the artery and become part of a plaque.

Um, heart attack symptoms. Any sort of pain in the upper extremity can be a symptom of a heart attack. So for big patients, I’m thinking something else is going on. They’re having neck pain or shoulder pain. And 45 percent of all heart attacks are silent. Shortness of breath.  Once again, I’m not a cardiologist as you all know, so I’m trying to focus on the things that We can make a difference with, which are, the traditional natural things. Uh, so, these are his forms of stress testing. I’ll go about the EKG treadmill test. And there’s a couple of other forms of stress testing.[00:30:00]

And and now we have direct artery testing. So, there’s something called coronary calcium scan. Are you familiar with that? So, it’s an easy test to send your patients with. A lot of them are guessing whether or not they have heart disease. According to your calcium scan, you can get it for two, three hundred bucks.  It may not be covered by insurance, but a lot of the labs offer it. And it will give you an idea of how much calcified plaque you have in your arteries. Yeah calcium is bad, but what’s worse is soft plaque. So, soft plaque is more vulnerable to break off and lead to a myocardial infarction. Thank you. Now, traditionally, cardiologists have run what’s called cardiac catheterization, also known as an angiogram and this is where they run a catheter through the leg through the arteries of the heart, visualize it, and they, that’s been done for a number of years.  One of the problems with that test is that they have the same patient get tested by different cardiologists. One of them says it’s a 30 percent block, one of them says it’s a 50 percent block. So we now have a more advanced test, which is the CT angiogram with artificial intelligence. And that’s who can we help.  So we have a representative who who’s then come up to tell us a little bit about the Cleerly Health scan.

Edan:  Awesome. This is fine. Perfect. This. Okay? Perfect. Can you guys all hear me without the mic? I’m a little loud. Yeah. Okay.  Good evening, everyone. My name is Edan. I’m actually your point of contact here for All Things Cleerly. I live here in Venice Beach. Dr. Howard Elkin actually was a big user of ours.  When I heard of his passing, it was actually pretty tough. I used to use the Martins Fair. Might be better. Yeah. When when I heard the news about Dr. Elkin, it was actually a pretty big blow to us. We do a case review for most of our patients for the providers, pretty much every single patient you send through.  We do a case review with our medical team. We had an extra view with Dr. Elkin on Monday before I found out, so it was a tough blow for us, but I’m going to spend the next eight or so minutes just [00:33:00] talking to you guys about Cleerly and then if you guys have any questions after the fact, I’ve got my cars as well, so we can chat about it, but a little bit about the company, so our founder, his name is Dr. Min and he’s a cardiologist by trade.  He focused on research for most of his career. And realized in finding his, in all of his findings that he had a chance to really, hopefully change the world. And so, he started the company with the intent to create a world without heart attacks, which as you guys all know is no small feat. But Dr. Min likes to say that if we’re successful in our endeavor, it’ll be a silent revolution, whereby the number one killer in the world simply drops to number two.  Number 3, so on and so forth. So he’s very humble in his pursuit, and the individuals within the organization, we all strive to be the same. And in order to do so, we follow in the footsteps of cancer prevention. So if you can recall back in the day before there was an emphasis on the prevention of cancer, an individual, a patient, would walk into the doctor’s office with a sign or a symptom, and by then we’d know it’d be a little bit too late.  Thus began the revolution for the prevention of cancer, and in [00:34:00] today’s day and age, If you combine all of the deaths associated with all of the cancers, they amount to less deaths than cardiovascular. Now the reason behind that is because the tools that we currently had simply didn’t shed enough light into what we needed to know.  For example, if you ran an advanced lipid panel such as the one that Dr. Weitz was talking about, it’ll give you a lot of amazing information about your patient’s blood chemistry. Let’s say the patient had elevated lipids and you were to work on lowering those lipids through natural supplementation, lifestyle modifications, or pharmacological pursuits.  And you were successful in lowering those lipids. The question becomes, okay, well, what’s going on within the coronary tree, right? We now hear all about these high ketogenic diets, right? So heavy lipids and their lipids are through the sky. But I can tell you so many cases of individuals that run their clear, these are clear, these are clean.

So it isn’t, like, to your point, it isn’t 100 percent about the cholesterol and about the magnesium as well. Similarly, if you were to run a calcium score, A calcium score will tell you [00:35:00] how much stable plaque there is, and to Dr. Weitz’s point it’s not necessarily just about the calcified plaque, it’s more so about the soft plaque.

So enter Cleerly, we’re the company that can talk to you all about the different types of plaque, where it is, and how much of it there is. Now we’ve come to understand that there are three different types of plaque. The first is your calcified plaque, which in our software would be denoted as aluminum, this is just your calcium, but you’d get out of a calcium score.  The second is non calcified plaque, which in the software looks like it’s yellow plaque. This is slightly softer than the calcified plaque, slightly more at risk for rupture. And then the third type of plaque is called, it’s just a fancy term for the lowest type, lowest density or the softest plaque, that’s called low density, non calcified plaque.  And so this stuff is the really, really dangerous stuff. We’re based in research and so we currently have unpublished data that suggests that just one cubic millimeter of this stuff increases your risk for an event threefold. [00:36:00] So consider a person that has a hundred cubic millimeters of total plaque, right?

All three plaque types. That’s considered a stage one patient, which we’ve talked to you about, which is pretty Low, but if they just have one cubic millimeter of that to be the low density stuff that increases your risks.  That’s basically actually all I wanted to do on the slides Most of this talks a little bit more about the company and how to actually obtain the results But just know that from a resource perspective we focus on education first and foremost So we want you to understand when you get these reports you understand number one what they mean What to do about them from a medical therapy perspective all the options available and when to follow up So we’re not the type of organization that just kind of throws something at you and says, Hey, good luck, figure it out.

We literally walk you through and every single patient that you send our way, we actually set up a 30 minute Zoom session to talk to you about the results of those patients. So just know that you always feel supported. If that’s the gist do you have a couple of minutes maybe for questions? Yeah. Yeah.[00:37:00]

Any questions? Sure. So a doctor in Valley mentioned to me, Brad mentioned that I have Ibogaine, it can contaminate, literally, short of wells in my patients. And I said, Oh, there’s something called Heart Something. And I’m saying that to make you look at that list, but I’m sure you’re aware of the competitors and I’m just so curious what the difference is.

I love that you brought that up. So, what your doctor was referring to was HeartFlow? Yes. HeartFlow is a company that evaluates flow, otherwise known as FFR. FFR is used in order to determine what’s called ischemia. And so, from a, Prevention perspective, if a patient is already ischemic, the answer is the cath lab, right?  But from a functional medicine and preventative perspective, we’re trying to get it, catch the disease before they need to get to the cath lab. And unfortunately over 52 percent of heart attacks are in asymptomatic patients. And so if we’re really going to work on stopping it or preventing it before we [00:38:00] even get to the Cath Lab.  Plaque is what you look at first. Once you look at the plaque, if there’s a stenosis that’s greater than 40%, we call it the gray zone, between 40 and 90 percent stenosis, that’s called the gray zone. The question is, are those plaques that comprise of 40 to 90 percent stenosis in one of the vessels, are those ischemic?  And does that patient then need to go to the Cath Lab? Now there’s more and more evidence that show that stenting lesions, depending on what type of lesion they are, don’t necessarily prove to actually improve anything other than symptoms. And so people are starting to move away from sending patients to the cath lab and intervening through stents and or CABG.

Because the fact of the matter is, it may just alleviate symptoms for patients that are experiencing symptoms, but it doesn’t actually improve things. The things that does improve is natural supplementation, pharmacological pursuits if needed, and then just lifestyle. Lifestyle is the biggest thing. The last thing I’ll add to that is it’s been 10 years since [00:39:00] FFRCT has come out and cardiovascular disease has not improved.

Hey, so when lifestyle is spot free, it may be reattacked, re approved. What’s the time exactly? It really will. Now, it’s interesting. I say this anecdotally. Because it’s difficult to put it in from a study perspective however, we can give you example after example of individuals that may be slightly overweight and, or simply aren’t exercising, or aren’t getting enough sleep, or aren’t, or are just too high stress, they’ll obtain it clearly, they’ll obtain it clearly a year later after losing 30 pounds, or whatever it might be, and the amount of Maybe not necessarily plaque transformation, more so maybe just the slowdown of actual plaque formation.

Is there anything else you should be aware of? I would assume so. I don’t know 100% the answer to that question 100%, but I would assume so. If you’re not getting good sleep, then it’s going to be affecting the [00:40:00] cardiovascular. Yes. So, what locations do this test? So, another, another great question. So, from a Southern California perspective, we’re very, very lucky.  We’ve got a ton, from Santa Monica, to Beverly Hills, to Torrance, all the way down the coast into San Diego. So, again, that would be a great question. Just reach out to me, say, Hey, I have a patient in this location, where do I go? None of the out of hits, though, right? We do have, we have we have Northridge, Westlake Woodland Hills, got a lot of spots.

Yes. Can you talk to us about her background, too? Sure. And she told me that she cares about it. We’re close. We’re hoping. Yeah, we’re really, really close. We’re hoping by January 1st. Yeah. Lots of questions, but how much time do we have left? Maybe, maybe we’ll take the rest of the questions offline?

We’ll check. Let’s get started. Sounds good. Of course. Thank you. Let me get this up. I do. That much. Do you guys have this [00:41:00] list of evidence each who had plaque reversal? Yes, we have. I will tell you that amongst the blockbuster pharmacological pursuits that the doctor just spoke about anecdotally, PCSK9 inhibitors.

Okay. So your Repatha and then you’re new with Veo. The PCSK nine inhibitors are pretty much the only medications out there right now. that people are seeing actual regression in disease. Once you have the indices, currently with what we know, regression is not the goal. Transformation is the goal.  It all starts off as soft black, or transform it into the calcite. Do you get regression? Do you get the start? Yes. That potential solution.  Oh, thank you so much.

Dr. Weitz:  Okay, great. So, there’s a couple of tests that some doctors like Dr. Mark Houston I mentioned him, he’s my mentor he uses a test called EndoPat to measure endothelial function. And there’s also one man using for his office called Pulse Weight Velocity. And then another test that’s often done is Carotid Ultrasound.  And there’s actually two different tests. There’s the Carotid Artery Ultrasound, and there’s also the Carotid Intermedial Thickness. The ultrasound better predicts events but the Carotid Intermedial Thickness can better measure the thickness of the plaque but it’s measuring it’s measuring the the artery in the neck, not the artery in the heart.

So, anyway, so here is an advanced lipid profile, so we’re doing good on time. Really happy. I think, I hope I have been talking too fast. Okay, great. So, this is a Boston Heart. This is one of my patients. [00:43:00] So you can see here where there’s LDL-P, which is the particle number and small dense LDL. These are both somewhat elevated.

We still, there’s a lot of controversy as it relates to HDL. So HDL is a, so-called good cholesterol. And the reason why it’s called the good cholesterol is that ideally, HDL can do reverse cholesterol transport. So, once the cholesterol in the body is produced in the liver, and then some of it makes its way into the artery, the HDL can take the cholesterol from the artery, bring it back to the liver, which is reverse cholesterol transport.  But, it’s, we’re still trying to figure out, how do we know that the HDL is doing what it’s supposed to do, and just having a higher HDL doesn’t necessarily mean that it’s going to happen. Having low HDL is not good. So, one way to look at it is to ook at HDL particle size. The latest data seems to show that all the different HDL particle sizes can be beneficial.  So Cleveland has a test for HDL functionality, so that may be the direction we need to go.  Boston Heart uniquely has this test that looks at whether or not you’re a cholesterol absorber or a cholesterol producer. So here we have a patient who’s a high cholesterol absorber. So this can help you with your strategy potentially.  So, for example, on a natural front, you could use Berberine or you could use plant sterols, which help the block cholesterol. If the person’s a cholesterol producer, then you want to think more about red yeast rice, tocotrienols, and some other compounds on the drug front. If they’re a cholesterol producer, you should be thinking about Statins, PCSK9 inhibitors.  If they’re a cholesterol absorber, you can think about Zetia.

So, some of these are other markers. This is 5 percent of markers for inflammation in your arteries. So we always want to look at HsCRP, this marker, LpPLA2, and MPO, myeloperoxidase. Interestingly, we had a number of patients with mild COVID. We found a lot of patients with elevated MPO.

And I think this is a marker of inflammation. That occurred as a result of inflammatory, so, obviously looking at glucose and insulin.  I know a lot of doctors don’t look at insulin, but it’s so important. If you’re managing your glucose, but you’re having to use a lot of insulin, obviously you’re developing insulin insensitivity.

Here are a few genetic markers, so, this patient had a one copy of Apo E4, and that put him at risk. This is actually a guy who came into a really good chain, at 40 years old he was fortunately following I think what’s wrong, nutritional program for him, which was he was doing more of a Keto Paleo type of diet and he pulled a group of coffee, and he ended up having a heart attack at 40.  Yeah, it wasn’t a severe heart attack, but, it was a wake up call. And so, ApoE4 probably is one of the risk factors. This is a test to see if you can tolerate satins or if they’ll be effective.

Omega 3s, everybody should be measuring Omega 3. We try to get the Omega 3 index above 10. I myself, I take 6 grams of DHA a day.  I take it with tocotrienols to prevent the oxidation of the polyunsaturated fat. Let’s see.

And I have Q10, HOMO 6, HOMO 12. So this is a panel we run for Vibrant Health. It doesn’t have all the markers we want. They don’t have LDL P. They don’t have a few of the other things I would like to have. But, Vibrant Labs, Vibrant America Lab, I don’t feel familiar with them. Like, they’re a great lab for functional medicine practitioners because they’re kind of a one stop shop.  There’s not much you can’t get from them. They have some great toxin tests, they have all the gluten sensitivity tests. I put together a panel, I have set up a male panel, a female panel, and then we modify it. And so, this is the advanced lipids.  This is the inflammatory markers right there, so you can see this patient has [00:48:00] elevated homocysteine and IHS CRP, that should be below 1. Unfortunately, they don’t have Lp, but Lae, Lp, or a small Nth Lp out, so that’s good. Insulin resistance, you can see that here with insulin 16, they have hemoglobin, you can see 6.

2,  full fiber, more hormones but I’m not going to talk about all this. Uric acid, we’re always looking at uric acid dispersing it to the Lp, uric acid. So, There are a bunch of natural supplements that can help lower uric acid. According to David Perlmutter, if you want to get your uric acid below 5. 5, So, technically over 7, it tends to increase significantly your risk of gout. That’s probably what you’ve heard your [00:49:00] cat say, mentioned before.

IGF 1, that’s an interesting part of SOFR 1. In Japanese, IGF 1 is agropoxy for growth hormone. So, you don’t want your IGF 1 to be too low. But we supported this model long ago. If your IGF 1 is too high, And that increases your risk of cancer. But, his view is not one I necessarily agree with all of it.

He also recommends a lower protein intake. But, he said, Zach, you want to keep the IGF 1 below 175. Make a trace. And so, this is a core area Janssen scan. This is something that’s a live plant. A live plant. We don’t make everything there.

This is one of Howard’s slides, I think so his patients, as you [00:50:00] can see, they have a lot of inflammation, HSCRP, they don’t have enough nitric oxide they have a lot of slow hits, LDL, low HDL, so this person really is at a lot of risk, so it’s looking at all these different factors, not just one thing, and when it comes to ApoB, They have a perfectly healthy able P of 59.

So if, we’re gonna follow Peter Attia’s recommendation for just focus on ApoB, but unfortunately it’s not enough. We need to look at more markers. So that’s one should be all want that very high homelessness needs. So this really has a lot of risk.

And this is part of by, in the heartland, we got people to translate these, [00:51:00] to get into the operative machine. Now you can see it even slower. But it was changing so much now. So that’s one H2, Camp, Spinetop, and Chinkosan. Okay, how do we reduce Cardiac Coronary Heart Disease? So, from a lifestyle perspective we’re obviously stop smoking, healthy diet, and we’ll talk about some of the ideas of what the most heart helping diet is. Exercise, everybody should be exercising, everybody should be doing some form of resistance training, everybody should be doing cardiovascular training, everybody should be doing stretching, everybody should be doing balance training.

You’ve got to reduce the [00:52:00] visceral adipose tissue around the heart and the organs, that’s most associated with cardiovascular disease. Sleep, super important. Gasting is beneficial. Hormones I’ve become a believer in that we should try to have optimal levels of hormones. And I do think that the research shows that when you take bioidentical hormones, you’re healthier.

Or as you can see, I am a specialist for cardiovascular risk it’s a reason why we can have a lower risk of heart disease a bit later on and increase the depth of that cause. What about testosterone? Well, there’s some controversy about it, but A lot of the data seems to show that testosterone, say as long as you carefully monitor, the thing that can happen with testosterone is you start producing too many red blood cells, hemoglobin, and that goes out.

If that happens, your blood gets thick and stickier. And that’s not a [00:53:00] good thing. So everybody takes testosterone monitors in. But I think for men if everything else is healthy, you can have a good testosterone level later into life. For example, I’m 66 and my testosterone level is 1000. So I never take testosterone.

Alright, so we have the modified Mediterranean diet. Mediterranean Diets. I think it has a lot of research to be done in why it’s a Mediterranean diet. Extra virgin olive oil, super beneficial for cardiovascular health. Of course you gotta get Duplain. Olive oil, and that’s a whole thing. I had a whole podcast about how to select the right olive oil.

It’s been penetrating diet, I have to say. It’s lots of vegetables, fruits, legumes, even though I’m not touching them, do you see it? No. Fish, is red wine beneficial for the [00:54:00] heart? Generally don’t think it is. But for a while, it was the French Herodotes, I think. Drink a lot of wine, have healthy hearts, and it gives the benefit that the Red Queen, Red Wine, can increase HDL levels.

So, right now, everybody seems to be down on Red and White Maybe, maybe there’s some benefits by consuming a lot of alcohol, I mean, the poor folio diet, there’s several studies using this particular diet as a way to reduce risk of cardiovascular disease, and it has specific components. that have been known to help have more favorable lipids, and those are specifically soy plants, cereals, nuts, and soluble fiber.

Soluble fiber was a big thing for a while when you had to eat oatmeal because of soluble fiber. I do think that fiber is super important. It’s [00:55:00] probably not because of the fiber, and by the way, this is coming directly from Dr. Musi, because the fiber belongs onto the cholesterol and T synaptic system, but rather the fiber has a beneficial effect on the microbiome.

that decreases our risk for heart disease. And we’re learning more and more about the importance of the microbiome. For example, the most popular drug for diabetes is Hormin. And how does that Hormin work? You can figure it out. And a lot of the data seems to be pointing out that Hormin has a positive effect on the microbiome.

And, by the way, Berberine is a natural version of that Hormin. And it works largely through the microbiome. Lower carb diet can be beneficial especially for patients with insulin resistance and diabetes. There’s some data on vegetarian diet and, a lot of people swear by vegetarian diet [00:56:00] and for some patients it’s going to be the best choice for them.

I’m trying not to get beat up by eating something when I get out of here. I’m just kidding.  So, when it comes to overall dietary recommendations, we certainly want to avoid sugar and high glycemic carbohydrates. So those are carbohydrates that cause a huge spike in blood sugar, things like bread, cookies, etc. etc. Ultra processed foods. Somehow we came from junk foods, processed foods, now it’s ultra processed.  Like, ultra processed foods are not good. Despite the fact that the U. S. Dietary Guidelines, the folks that made the U. S. Dietary Guidelines came out with something poor like several months ago saying, there’s no food, and ultra processed foods are not healthy. Okay formula of all health a number of foods that will help to manage [00:57:00] livings.

We know that nuts are super beneficial. There’s a few plants that I use. I have a whole bunch of different nuts. Almonds, pecans, walnuts. Walnuts also have some, magnesium in them. Nuts and seeds are super beneficial. I like to add flax seeds. Thanks. Buy the flaxseeds organic and store it in the fridge or freezer and grind it yourself.

Because flaxseed oil is very highly oxidizable, just like fish oil is, so you don’t want to buy random flaxseeds. And they’re most likely to be oxidized because it’s been stored for a while. But Flaxseeds are super beneficial for a lot of things. So, in, so, in the functional medicine world, there is some doctors that have written some books about sodium, say, There’s nothing to worry about with sodium salt, it’s not a risk factor, eat sodium, eat plenty [00:58:00] of sodium according to Dr. Houston, who I trust, salt is absolutely harmful to the vascular system, and generally speaking, we want to keep our sodium down, and we want to keep our potassium and our magnesium up, and it’s not just because it’s Increases blood pressure, but it damages the arteries, makes the arteries stiffer. This is coming from Dr. Houston. I’ve seen some data on him as well. I trust what he’s saying. So, we want to make sure you’re getting lots of potassium and magnesium. Potassium, shoot for at least 5 grams a day, and probably at least 1 gram a day of magnesium. Keep your blood pressure low.

What about eating fat? I can’t necessarily solve all these controversies, but Trans fats, for sure, we know are [00:59:00] not good. Don’t eat trans fats. Omega 3s, we know are good. Monounsaturated oils, like olive oil, we know are good. Everything in between, there’s a question that’s up. The data seems to show a modest amount of ants is healthy on a weekly basis.

What about coconut oil? I think a lot of us in the functional medicine world feel that coconut oil is a healthy oil. I know when I was cooking my vegetables with coconut oil, my small pants helped me out a lot. So I stopped, I switched to avocado oil and variety cooking, according to Dr. Houston, coconut oil is not good and the reason why is because it has long chain saturated fat.

So, what about saturated fat? That’s the big controversy. Saturated fat ban was being contributed to heart disease. Well, [01:00:00] it depends. Saturated fat actually is there’s a number of types of saturated fat. So here are saturated fats with 12 or more carbon chains that are known as long chains. Saturated fats.  Those are more correlated with heart disease. Medium gene, 12 12 carbons or less, and extreme gene saturated fats are not associated with heart disease. So, what happens when you take patients and you say, Let’s remove the saturated fats and let’s substitute something else. So when you substitute polyunsaturated fats, the risk of heart disease seems to go down.  When you substitute carbohydrates, especially refined carbohydrates, the risk tends to go up. There’s going to be meetings that are not going to be happening. Epidemical might be the way to [01:01:00] speak at them. I’m done. He has plenty of medications, it’s carb rich, and we have prescribed medications, but we need to be aware of them. Fibrates are drugs that were popular, they’re not that popular, my understanding is, among cardiologists but it’s a way to reduce cholesterol. Most of the cardiologists are going to be recommending statins to start with.  There’s water soluble, fat soluble statins, That sodium or statins seem to be more effective and better tolerated, generally speaking. So, those are Suprastat, Crestor, and Propastat. Zetia is a drug, I mentioned it before, it helps block cholesterol absorption. It doesn’t have the side effects the potential side effects of statins.

So, Zetia is a drug that can either be added to a statin, or patients who are intolerant to a [01:02:00] statin, don’t want to take a statin, and still want to take a medication you can do a combination of Bempedoic Acid, which is the neurospinal neurostruts, that helps the lower lipids, and combine that with Xetia, and get a really good effect.

Problem with endodermal gassing is that it’s expected to be very nutritious and useful for recovery. Of course, aspirin. We know that clotting is a factor, so, I think thinner blood is probably good, like, which would be two things, so, taking an aspirin, which is recommended for everybody, like, some patients have bleeding, and so it’s not good for them, so, not an idea. From a natural perspective, if you take enough fish oil, I do prevent adrenals, uh, you blood is likely to be thinner, take a [01:03:00] lot of curing as well.

Uh, you can use that kinase, hydrokinase, natural blood thinners, uh, so everybody’s talking about GLP 1 agonists like Ozembic. And, uh, everybody’s thinking of the weight loss, as you saw Oprah last night, looks like a totally different person. Um, they, they really work for weight loss. What are the side effects going to be?

I think there’s going to be a huge number of side effects because of slow GI motility. That’s one of the ways that they, uh, help with weight loss because people don’t get hungry because it sits in their stomach. Uh, so. We’ve, I know in my practice, we’ve treated a lot of patients for gastrointestinal problems, like SIBO, reflux, and decreased motility is a big problem, [01:04:00] so, uh, Dr. Pimentel has said that testing patients for SIBO, or on these drugs, is just, uh, is horrible. The microbiome is all messed up. We used to do IV chelation. It’s still done in some clinics. It’s a way to naturally reduce your cholesterol levels. Um, but I don’t think it’s done that often anymore. Did you see, um, here at CNN’s most recent article, it was talking about, which surprised me, how he, and I guess it was supported by evidence, I don’t remember the exact quote, but that PCSK 9 inhibitors and statins.

He was supporting young. Oh, a hundred percent. I guess he did. Peter Dean says, uh, he said on what this podcast said, we, you get your, uh, your a OB above 40 or like your LVL below 30 will eliminate cardiovascular [01:05:00] disease and doing it, whatever means necessary, which means stat, PCSK nine inhibitors, et cetera.

So, I showed you a slide where a person had a good April 8th, but they had a lot of small events, they had a lot of information, so it’s, in my opinion, it’s the whole picture. It’s not just one market. It’s, it, it takes one, just one market. Alright, Stats, uh, um, so, uh, Stats, uh,

I think in a functional medicine world, we tend to think that statins are absolutely the worst thing in the world, and everybody has side effects. Um, I know a number of doctors will say that 20 percent of their patients are on statins and muscle pain. Uh, according to studies by the big pharma, [01:06:00] it’s like 1%.

It’s definitely 1 in 1%. Uh, I don’t know if it’s 20%, it depends. Uh, there are studies where they give people a placebo instead of a statin and they get muscle pain. Uh, so, it’s hard to say, but there are definitely a percentage of patients who are intolerant to statins. They usually can tolerate Red Yeast Rice and other agents.

Um, one of the things that is happening still is they actually stabilize plaques. They dry out some of their cholesterol, they tend to calcify them. So, as I mentioned, I think a lot of us see calcium and all my god, that’s the worst thing in the world. But, uh, a stable plaque gets better than a soft plaque.

So, That may be one of the mechanisms by which statins are beneficial. Uh, I, I actually heard the, [01:07:00] uh, with the doctor from your company, uh, Joel Kahn’s podcast, and he was saying you can’t reverse plaque, but that if you, uh, calcify it, it will look smaller, and, and that’s what’s really happening. According to Dr. Busey, you can’t reverse plaque, and there’s a number of studies that have shown it, and, and that’s what’s happening. Uh, I guess we’ll, we’ll keep working it and find out. Um, for sure, SACWIS inhibits quite a number of nutrients that won’t be produced along that pathway in that SACWIS blot. We all know about CoQ10, so everybody who’s on the SAC should be taking CoQ10, absolutely.

CoQ10 is super beneficial to the heart. And often in higher dosages, Joel Kahn on his podcast said that, on average, he is prescribing his patients 400 and sometimes 800 milligrams a day of OQ10. [01:08:00] Um, it also can be in sex, also can be in production by eating, maybe some fats, so Trinols, Carnitine, 5K, um, medical interventions.

Thank you. As we heard earlier, neither stents nor bypass surgery, if the patient is stable. So if the patient’s got a blockage in the midst of an event, they open up the artery with a stent, that’s different. But if the patient is stable, they get a stent, they get a coronary bypass surgery, it doesn’t reduce your risk of death.

Alright, here we go. This is good stuff. You wanna take a picture of this slide? I got several of some rice. It, the same pathway. It’s often [01:09:00] un under, uh, underused, uh, under dose. So I just had a patient in my office yesterday. Uh, he was intolerant to, uh, stat. His cardiologist put him on Reggie’s rice, but they put him on 1200 milligrams.

You’ve got to do at least 24 milligrams a day if you want it to be beneficial. Sometimes it’s 48, that’s taken at night. And that’s usually when they prescribe the sac as well. Tocotrienols, when taken with Red Yeast Rice or a statin actually improves the effect. Are you familiar with tocotrienols? Tocotrienols are a form of vitamin E and vitamin E is a family that includes tocopherols and tocotrienols.  So tocotrienols have some unique properties. [01:10:00] So I’m a big believer in Toco tree. And why Statin at night? Um, because body tends to produce together, tends to produce cholesterol at night.

Um, Niacin, as I mentioned, Niacin is maize nutrient that has all these benefits for cardiovascular health. So, Niacin is one of the few ingredients, as I mentioned, you can lower Lp, but why? It can increase HDL. It’s one of the few things that can take LDL particle and make it bigger. We use modest doses, just like 500 milligrams, and at that level, you You know, there’s very few potential side effects.

It was common for Cardiologists to prescribe niacin. Typically, they would be using 2 grams, sometimes 3 grams. And at that [01:11:00] level, sometimes there are some side effects. Of course at any level you might get some flushing, but flushing is not harmful. Plant sterols are another good supplement that inhibits cholesterol absorption that will do one than three grams a day.

Berberine is an amazing supplement for cardiovascular health. One of the few things that has been shown to reverse plaque you, but studies, uh, and as I mentioned, , uh, natural metformin. It’s also a natural PCSK9 inhibitor. This study showed a 3.2 percent reversal of plaque in 4 months. Just think of Berkeley. Citrus Bergamot is another one to add.

If you have a patient on Red Yeast Rice and you’re not getting an amount of improvement, you want to add Citrus Bergamot, Omega 3 fish oils, [01:12:00] super important. Um, despite some of the studies that are coming out of the New England Journal of Medicine or the AMA Journal, ever notice that Um, there’s like a hundred studies that have come out over the last several years on the benefits of fish oil.  But the two that show that fish oil is not beneficial or harmful, those are the ones published in the New England Journal of Medicine. So, I think there’s just overwhelming evidence that omega 3 fats are beneficial.

Question:  What do you think of krill versus a combination of fish?

Dr. Weitz:  So, my understanding is, is most of the data supports a sufficient amount of Omega 3.  At least 2 grams a day. You wouldn’t have to take like 25 krill capsules to get 2 grams. So, unless you, unless you want to take that much, I say get a good quality, high dose of fish oil, 1, 000 milligrams, [01:13:00] tributyls, or more. Raman Sulfate or Fucoidan Sulfate, so those are seaweeds that are included in specific supplements that can help to support the glycocalyx of the endothelium.  And so, one of them is called Arteriosil is a very popular one. EndoGel is pro regenerative.  Regenovasc, these are, uh, supplements that specifically are going to reduce your risk of coronary artery disease, help significantly with blood pressure. You also want to include a nitric oxide stimulator.  Those are super important for blood pressure as well. I mentioned the importance of the glycocalyx producing nitric oxide. Nitric oxide is a gas that’s produced for a short period of time. We can use things like L Citrulline, [01:14:00] beet root extract and some other things that stimulate nitric oxide. Glucosamine sulfate.  Glucosamine sulfate and chondroitin sulfate. These are popular joint supplements that have been shown to support the glycocalyx. So I mentioned the glycocalyx as opposed to proteoglycans. And it turns out there’s three or four studies showing significant reduction in risk. Look at this: 39 percent reduction in all cause mortality, 65 percent reduction in cardiovascular mortality from taking glucosamine sulfate.  It’s amazing. I don’t know why everybody’s not talking about this. When I saw this study coming out, now there’s another study, there’s another study that came out last year. I emailed Joel Kahn and said, wow, is this real? He goes, [01:15:00] yeah. He goes, there’s three or four other studies. So, put all of your patients on glucosamine sulfate.  Aged garlic. It can reduce soft plaque, it can reduce blood pressure.  And Nattokinas, which is a natural blood thinner.

CoQ10 also helps. It’s, as I mentioned, it helps to lower LDL in the brain, it supports the heart muscle, mitochondria, part of our program to rebuild the patient with heart failure. It includes CoQ10, D ribose, L carnitine, and Iodocybin. Methylated D vitamins to lower homeopathy. Lycopene. improves HDL functionality, Dr. Houston developed a supplement with 20 mg of Lycopene and several nutrients for one of the components. [01:16:00] Uh, we wouldn’t want to use specific nutritional strategies. The lower LDL, LDL A, I think I mentioned, most of these, uh, What do you, what do you do about oxidized Lp? Uh, Yesin helps, so does popocranate.

There’s some supplements on the market that contain popocranate and some other, uh, antioxidants, resveratrol, citric ergomide, zirconianols, curcumin. I don’t do HDL functionality, I just mentioned glycopene, omega 3, and again, it’s a B vitamin.

So, here are some books that I recommend. Dr. Houston’s book. This is Jonathan Bowden’s book. Johnny is right here in our audience. Johnny is a very prolific author. Uh, he’s written like 15 different books. [01:17:00] He wrote this with Dr. Sinatra. Yeah, about a year and a half ago, actually, Johnny, Dr. And Dr. Sinatra’s son and I, we all did a tribute to Dr. Sinatra when he died. We did a podcast together. Um, so here’s a book by Dr. Sinatra. Here’s another book by Dr. Mark Huston. This is Joel Kahn’s book about Lp and LDL. Mark Houston has some amazing articles where he writes. There’s all these different supplements, the Cali Chloroate, warm supplements, uh, Ectoide Pathways.

So, great resource. You can take a course with Dr. Houston, teach us how for you for him. You should definitely do it. Um, so, thank you. Please subscribe to my podcast. Tell your colleagues about these names. We’re very educational. We get great [01:18:00] speakers. Um, and it’s, it’s, Costs nothing. It’s a great way to use your network.  Uh, let’s get back to networking. Time to get back in person and support Integrative therapeutics. Thank you.

Dr. Weitz:  Yeah. Okay. We have to leave unfortunately. Thank you. 


Thank you for making it all the way through this episode of the Rational Wellness Podcast. For those of you who enjoy listening to the Rational Wellness Podcast, I would very much appreciate it if you could go to Apple Podcasts or Spotify and give us a five star ratings and review.  Thank you. As you may know, I continue to accept a limited number of new patients per month for functional medicine. If you would like help overcoming a gut or other chronic health condition, and want to prevent chronic problems, and want to promote longevity, [01:24:00] Please call my Santa Monica Weitz Sports Chiropractic and Nutrition office at 310 395 3111 and we can set you up for a consultation for functional medicine.  And I will talk to everybody next week.

Ryan Smith of TruDiagnostic discusses the Tru-Age Test of Biological Aging with Dr. Ben Weitz.

[If you enjoy this podcast, please give us a rating and review on Apple Podcasts, so more people will find The Rational Wellness Podcast. Also check out the video version on my WeitzChiro YouTube page.]

Podcast Highlights

3:48  DNA Methylation is the best marker we have to understand biological aging. DNA methylation is an epigenetic modification, meaning that certain genes are turned on or turned off.  And methylation is the main switch for turning on and off genes. Some genes we want turned off and some we want turned on.  DNA methylation is now very repeatable and the most predictive of ways to measure biological aging. 

6:28  The History of Biological Methylation Clocks.  The key factor to understand is what is aging, which is difficult to define?  One question is, is aging a disease?  If we recognize it as a disease, then our regulatory framework will allow there to be drugs to treat it.   There are first generation clocks like Horvath and Hannum, and second generation clocks like Grimm Age and Pheno Age, and now we’re into third generation clocks.  First generation clocks like Horvath were really designed to predict chronological age and they were originally designed for forensics in crime scenes rather than for health.  But then they noticed that those who were younger than their chronological age, were protected from negative health outcomes, which was very exciting.  If aging is a disease, then it is the biggest risk factor for every chronic disease and death by a large margin.  So aging is important for our health.

 



Ryan Smith is the CEO of TruDiagnostic, who offer the TruAge test, which is the best commercially available way to measure biological aging by measuring DNA methylation.  Their website is TruDiagnostic.com.

Dr. Ben Weitz is available for Functional Nutrition consultations specializing in Functional Gastrointestinal Disorders like IBS/SIBO and Reflux and also Cardiometabolic Risk Factors like elevated lipids, high blood sugar, and high blood pressure.  Dr. Weitz has also successfully helped many patients with managing their weight and improving their athletic performance, as well as sports chiropractic work by calling his Santa Monica office 310-395-3111.

 



Podcast Transcript

Dr. Weitz: Hey, this is Dr. Ben Weitz, host of the Rational Wellness Podcast. I talk to the leading health and nutrition experts and researchers in the field to bring you the latest in cutting edge health information. Subscribe to the Rational Wellness Podcast for weekly updates, and to learn more, check out my website, drweitz.com. Thanks for joining me, and let’s jump into the podcast.

Hello, Rational Wellness Podcasters! I’m very excited today to be discussing biological aging, which is one of the topics I’m very passionate about. We need to, it’s helpful to have ways to gauge our biological age as compared to our chronological age so we can find out how we’re doing in our longevity quest.  Are we on the right path? Are we aging slower? biologically than we are chronologically, which of course is the goal. And one probably the best way to do that is with methylation, biological aging tests, looking at DNA methylation, And the best commercially available way to do this is through True Diagnostics who offer the True Age Test.

And today we have Ryan Smith, the CEO of True Diagnostics to discuss biological aging and the newest variations of their tests that’s available that can help us not only to understand how good a job we’re doing with our biological aging, but perhaps with the newest version, giving us some way to figure out what sorts of diet, lifestyle, supplement, other recommendations we can make, particularly to help us improve that biological aging.  So [00:02:00] Ryan, thank you so much for joining us.

Ryan Smith:  Yeah, thanks so much for having me. I know it’s been a while since we talked about the topic and a lot’s happened.

Dr. Weitz:  Absolutely. So let’s start from the beginning. How did you start True Diagnostics and, how did you get involved in the field of DNA methylation, biological aging?

Ryan Smith: It’s a long and convoluted path. Biochemist as an undergrad, becoming a med school dropout, after finishing all the actual educational material, I got to the clinical portion of my third year and really hated it and decided to do something different.  Ended up creating a compounding pharmacy that was dealing in this sort of cash pay, preventative, integrative wellness space. And prior to that I had no idea that this existed, but I loved that there was a community focusing on preventative medicine in a true way.  It’s certainly something always easier to prevent than to treat.  And and so got really excited about that. Our pharmacy grew really rapidly. We were the fourth fastest growing company in healthcare. And then, but we always knew that we wanted to to test a lot of our products to see how they were actually to see how they were actually affecting health span and lifespan.  And that brought up this idea of these biological age clocks as surrogates to see if they were effective tools to measure this process.  I got really excited about that and I got excited about the potential applications of this biomarker, DNA methylation even beyond aging. So we basically sold that company in 2020 to start TruDiagnostic.  And now we have our four year anniversary this week and as a result we have built the largest DNA methylation database in the world and have created a lot of new algorithms to be able to read the information we find in your epigenetics. 

Dr. Weitz:  Right.  Perhaps explain what is DNA methylation and why is it a better marker for biological aging compared to other biomarkers?  I guess some people use GRIP tests. We have VO2 max. In the past, it was a telomere length test, which I guess is still available.

Ryan Smith: Yeah, definitely. The so yeah, DNA methylation generally is what we call an epigenetic modification. So these are modifications above the genome which control your gene expression.  So how much is a gene turned on and turned off? And the reason that we need this is because obviously all of our cells in our body have the same DNA, right? Our heart or our skin, our brain, the same exact DNA sequence, but they behave very differently, right? You want your heart cells to behave like heart cells and your skin cells to behave like skin cells.  And to do that, they have to express different genes. So as your cells are going for. polypotent stem cells, which can do anything to the cell type that they’re meant to be, they’re doing it by turning on and turning off genes. And one of the mechanisms for that is DNA methylation. And DNA methylation really is the off switch that we sort of think about for some genes.

And so, DNA methylation in and of itself is not good or bad. Some, there are some genes we want turned off. There’s some genes we want turned on and different I would say abilities for each cell. And so that’s really what we’re measuring though, is from whole blood at True Diagnostic, what we’re looking at is all of those patterns of gene regulation, what’s turned on, what’s turned off, and we’re interpreting that for an outcome.  And DNA methylation is probably the most frequently used biological aging tool mainly because it’s the most predictive. I think you mentioned some really great tools like VO2 max and grip strength, physiological standards that we know deteriorate with age. But generally, they’re not as predictive as some of these other clocks.  And that’s really how we judge if a clock is effective. Can it be very predictive of outcomes? So if we’re seeing, for instance, 10 year age accelerations, does that mean there were worse risks for everything in the future? Or if we’re seeing 10 years deceleration, are we seeing that risk decrease?  And that’s really what these clocks specialize in, is they’re incredibly predictive of outcomes. And so, and, they’re very precise now. So we can, measure the same sample and get the same result. And then now they also change with therapy and that’s really what we’re documenting as well.  So we can actually show that these are responding to the things we already know improve biological age. So for all those reasons, they’ve become I would say a leading method in biological age quantification, mainly because they’re highly predictive.

Dr. Weitz:  Can you explain the history of biological methylation clocks?  I understand we’ve had the first generation clocks like the Horvath and the Hannum clock and then the second generation clocks like Grimm age and Pheno age and now we’re into the third generation. So can you explain a little bit about what this evolution in Methylation Clocks is about?

Ryan Smith: Yeah, definitely. Then, at the end of the day, it comes back to one question, which is pretty hard to define, which is what is aging, right? There are a lot of definitions for it where other people say, is it a disease or is it not? In these biological age clocks, we first wanted to

Dr. Weitz: Officially right now, it’s not considered a disease.  Yeah. Yeah correct. So there are people pushing for that so that perhaps there’ll be insurance coverage or something for somebody diagnosed or wanting to utilize therapies to promote longevity.

Ryan Smith: Yeah, definitely. And so we can have drugs approved to treat aging as a primary cause. We can’t do it right now because it doesn’t exist in the regulatory framework.  And the World Health Organization does have an ICD 11 extension code for aging to say a disease is caused by aging, but we can’t actually say that. Aging itself is a disease. And so there’s a lot of of controversy in this definition because there’s so many things that happen as we age. There’s sort of, multiple hallmarks of aging that change across our body.  But also, the things that we would even just see while looking at a person, right? They’re, the wrinkles, the gray hair, all these different things. And so aging is sort of hard to define, but in order to create a surrogate or to measure or predict the process, we really have to start with some definition.  And those definitions started in 2013 with Dr. Steve Horvath at UCLA, where he was creating just predictors of chronological age. That’s what we call those first generation clocks. So can we, by taking the methylation patterns of a blood sample, predict how old your chronological age is? And at [00:08:00] first, that wasn’t used for health.  It was used for, forensics, to date how old someone was, if they left their DNA at a crime scene, or to date refugees, to see if they were adults or minors, and therefore eligible for asylum. But then they started to notice a really big pattern, which is that those people who with this testing were younger than their chronological age, were protected from health, negative health outcomes.  And vice versa, those people who were older with this testing were at more increased risk for negative health outcomes. And so even though it was meant to be a chronological age predictor, it was sort of measuring some biological function that was predictive of outcomes. And that’s why it was so exciting.

It’s for the first time, We might’ve been able to measure the aging process molecularly that could then, tell us about outcomes. And the reason that this is important is aging is the biggest risk factor for every chronic disease and death. If you can think of a disease, aging is the biggest risk and not by a small margin.  We’re talking about 90 percent of the risk of Alzheimer’s is related to age.  Right. You can, and even things like, smoking and obesity, which we know are bad for us, pale in comparison to the relative risk that age is for most of these diseases. So age, we know this dysfunction, which happens with age, no matter how you define it is incredibly important to our health.

And so, whenever they started to see this molecular signature in 2013, it got people really excited. But ultimately it’s a little bit flawed, that definition, because we really don’t care about your chronological age, right? We know people in their eighties, who look 50 and we know people in their fifties who look 80.  That’s sort of the process we want to measure, right? We want to be able to predict what negative outcomes are going to happen. So you can maintain the most optimal function. And so the second generation clocks, instead of being trained to predict the chronological age of an individual, we’re trained to predict biological features.  So things like blood based biomarkers or in the case of probably grim age, one of the most popular algorithms it was trained to predict time until death. And time until death is a good surrogate for longevity because it’s a clearly defined outcome and, but it doesn’t take into a lot of other things.

Dr. Weitz: By the way, just stop for one second. Explain [00:10:00] what you mean when it was trained to predict time to death. We’re talking about using artificial intelligence. Is that how we’re training it? What do we mean by training it?

Ryan Smith: Yeah. So all of these algorithms have to be trained. And so generally what we’re doing is we’re taking methylation data and we’re telling an artificial intelligence system to take in this information and create a tool that can predict X that could be chronological age.  It could be how much you’ve smoked across an entire lifetime. It could be, do you have COPD or not have COPD? It could be, a wide majority. of things, but we’re training using artificial intelligence to read these patterns to predict an output. And and so that, that output again, originally was chronological age, but the, in second generation clocks, it became biological function.

So whenever these things are trained to bring time until death, what they’re really doing is looking at a group of samples that have been taken over the last 40 years and where we know where that person has passed away and then seeing if it can [00:11:00] predict. how long until a sample passes away. And and even our newest clock, Omic age that we just developed with Harvard is about 92 percent accurate within a 10 year time period of predicting death.  So we can predict death within a 10 year time period with really good accuracy, even over 75 percent within a four year time period. And so, we can get quite accurate at predicting that as an outcome.  There’s been a lot of criticism of methylation clocks that they don’t really help us predict it very accurately.

Dr. Weitz: They don’t really add much to it. There’s been a number of articles criticizing it. And you hear some of the prominent people in the health world saying there’s really no benefit. But But I think as these clocks are developing, they’re overcoming, I think, a lot of these initial criticisms.

Ryan Smith: Oh, exactly.  And I think that we do not shy away from the criticisms. I think that they’re valid. And in fact, I think [00:12:00] that we like to point them out because some of the, knowledge that we’ve gained from those clocks are no longer relevant and we need to sort of advance. And so, there, there are quite a few issues that have happened with the clocks previously.  The most I would say the biggest issue has been precision of these clocks, as I think you mentioned. If you take the same sample and then retake that same sample and perform an analysis, how close are those results? And even with the Horvath clock originally, it had a mean absolute error of right around 3.

9 years which is. Not helpful a lot of times, right? Because if you’re doing within a period of four years are you sure that’s technical measurement change or just because of your biological change? And ultimately we, we don’t want something that changes with the wind. We want something that is really good at predicting outcomes based on your own independent biology.

And so, so that’s been one issue that’s certainly been fixed. One other big issue is. do they respond to interventions we already know are beneficial for aging? So for instance caloric restriction is probably the most well validated therapy across animals and humans [00:13:00] to improve health span and lifespan.

But whenever we do this analysis with the epigenetic clocks, we see those first generation clocks we talked about, trained at chronological age, actually go up, which doesn’t make a lot of sense, right? And so these newer generation clocks do respond to what we would expect, But some of that first generation clock, again, is giving us bad data.

And it’s not just caloric restriction. It’s also things like senolytics, like disatinib and quercetin go up with first generation, but go down with the newer clocks. And so, that’s also been an issue. And again, you don’t want to put a tool in someone’s hands that gives you the wrong data. Otherwise you’re acting against your own self interest.

So those should have certainly been there. And then probably the last of those big issues is this idea of what do you do about it? And that’s ultimately. Yeah, the important part, right? Yeah.

Yeah. I’ve run the test a few times in the past and that was one of the big questions is, okay, so I see this rate of aging, it’s either good or bad.  And then, there’s no in, from the initial part, it’s a version of the test is really, was no way to say, [00:14:00] okay, here are some of the things you need to focus on to improve that biological aging in this particular person.

Ryan Smith: Exactly. And, that the question is, if we’re going to recommend caloric restriction to everyone, regardless of how they score, do we even need to test in the first place?  Right. It might make people more motivated, right. If you have a bad score, they might say, Hey, I need to really do these, it’s a, to have a lot of effort into this, but ultimately that’s been a huge limitation in the past as well is, you and I might be aging much differently, right.  We might have someone who smokes who has, their lungs are aging, their cardiovascular system is at risk, whereas we have someone else who maybe is a little bit overweight, doesn’t exercise, they might have more musculoskeletal aging or metabolic aging, and so this is different in every single person, and being able to identify the why we might be accelerated in aging or decelerated in aging is important because then it helps us to Set A Proper Protocol To Improve Our Health.

And previous to really I would say September of last year we didn’t have any tools which could provide that resolution. Now [00:15:00] with some of the newer clocks particularly the Omic H clock I referenced earlier as that death predictor that we developed with Harvard and then now the Symfony AH clock that we developed with Yale, those are able to provide some actual individual resolution to then tell you maybe what would be the best recommendations for treatment time.

Dr. Weitz: You mentioned senolytics and that’s one of the 12 hallmarks of aging. How well does your test correlate with those 12 hallmarks of aging?

Ryan Smith: Some of those hallmarks are hard to define as well, right? We might, some of those, for instance, like nutrient dysregulation, sensing dysregulation, or proteomic dysregulation.  Those are hard to define. And and even to have that data in match cohorts can be difficult. If we look at some of the ones that are easier, like telomere attrition, for instance, or senescence burden it can be a little bit easier. And so for instance, we see that really, although telomere length is extensively validated it’s got, over 20,000 studies on being a feature of aging, it’s really not that predictive.

It, it really only explains in a study in [00:16:00] Generation Scholarland, 2. 8 percent of the variance in aging whereas those methylation clocks are now over 60%. So as we’re comparing them, there’s some biomarkers that we would prioritize to be more important, and that would be certainly the methylation clocks over things like telomeres.

In the case of senescence is a wormhole to go down into because we’re about to publish this article with Yale that, that actually shows that even Senolytics. don’t actually change the epigenetic methylation signature of cells after they’ve received similitics.  And we’ve tried to create some surrogate predictors of that process. 

Dr. Weitz: What is, what does that mean?

Ryan Smith:  Yeah, we don’t know. But but generally we don’t think we can act with DNA methylation alone adequately capture I would say senescence signature is very well, at least at the moment.  That doesn’t mean that senescence is not impacting the methylation clocks or correlated with those clocks. They certainly are. That’s why we saw this additive inquisitin improve the epigenetic clocks, but it’s probably through a different mechanism, such as reducing the inflammation that’s oftentimes associated with senescence.  So DNA methylation I think it’s still good at predicting [00:17:00] outcomes of aging, maybe not directly good at predicting those individual features like senescence, for instance.

Dr. Weitz: Or, maybe those hallmarks of aging aren’t maybe the exact right hallmarks of aging.

Ryan Smith: Yeah, that that’s one thing too, and and with all of these things, one of the big issues is we don’t know what’s causative or correlative, right?  So we can pick up these signals that are associated with aging, but we don’t know which of those signals are causing, dysregulation versus a result of it. And so that’s something else that will be elucidated in these further years to make these clocks even more accurate and more usable.

Dr. Weitz: So now tell us about the Omic age clock that you’re using now.

Ryan Smith: Yeah. So we really have, I would say three clocks in our testing that we think are the best clocks to use. That would be the Omic age clock. As I mentioned, that one is one we developed with Harvard. And we did this with the idea that the clocks get better when you feed them more biological data.  So we’ve started with, Morgan Levine’s, first second generation clock used nine blood [00:18:00] based biomarkers. And now as the clocks have started to improve the idea is that the more information you can feed this model, the more it can pick out what’s relevant. And whenever we first started, there were nine hallmarks of aging.  Now there’s probably 15 to 19, depending on who you ask. And so one of the things we wanted to do with this cohort was measure everything. So we did, we measured in about 5,000 patients. We measured full genome. We measured the epigenomics. We did some RNA and transcriptomics. We measured, over 25, 000 proteins.

We measured over 7, 000 metabolites. And then we had all of their clinical data as well. And we put all of this together in one big model to predict time until death. And so that’s what the Ohmic Age Clock is. It’s probably the clock that’s been trained on the most biological data. And and trained to predict death as an outcome.

And it’s quite good at that. It is up there with grim age as being the most predictive clocks of mortality. So if you’re really interested in mortality, specifically in living longer, this is a great clock for you. But we include some features in it, which are able even to predict your blood based biomarkers.  So we can tell you about your C reactive [00:19:00] protein or, your HbA1c or your fasting glucose, which can give us more of that resolution on what to do about it. 

Dr. Weitz: So we see that you’re talking about predicting the C reactive protein without directly measuring the C reactive protein.

Ryan Smith: Exactly. Yeah. We call those epigenetic biomarker proxies.  And in the case of C reactive protein, our predictor is actually even just a better biomarker than C reactive protein across the board. We have better hazard ratios to every disease and more significance which means

Dr. Weitz: Really? This is fascinating. So what are you seeing is you took patients, measured their C reactive protein, measured and looked at their and then found specific patterns of methylation that correlated with those biomarkers.  

Ryan Smith: Absolutely happens. Okay. Yeah, definitely. And and so this is sort of how I, for anyone who’s not watching and it is listening, you can refer to the YouTube for some of these images I’ll show really quickly, but yeah, we measured all of [00:20:00] these proteins metabolites and clinical values.

And we said, Hey, can we predict these with DNA methylation? And in the case of CRP, we certainly see this. This is data from a lithiathin birth cohort where we don’t see a trend of aging with regular CRP, but we do see a trend with aging with our DNA methylation predictor of CRP. In addition to that, we see that our predictor is more precise, meaning it’s more repeatable.

In measurements, we see associations with cognitive function we don’t see with regular CRP. We see here is brain MRIs, where we look at DNA methylation CRP versus regular CRP, and we see that our DNA methylation version is 6. 4 times more predictive of brain outcomes than regular CRP. And here you can see that sort of the effect size and significance is higher in all of these different outcomes of CRP, BMI, cardiovascular disease, diabetes, all better than even regular CRP.

So we see that and we can actually see what genes are affected in this process. So the high highest weighted gene in our algorithm comes from the SOC three gene, which is a suppressor of cytokine signaling which makes sense, right? A [00:21:00] as this gene is affected, our levels of cytokines and inflammation, it’s gonna be affected.

And so with DNA methylation, we can actually predict these other biomarkers, all with just a simple finger stick blood measurement. And we incorporate those into our models. They can tell us why we’re aging faster or why we’re aging shorter.

Dr. Weitz: Fascinating. So if I was working with a patient who has signs of cognitive dysfunction, how could I use your test and then make changes to that patient’s diet, lifestyle, et cetera, and then use that test again to see if we’re, Improving that brain function.

Ryan Smith: Yeah. I think that’s an important thing to mention is that if you have a patient who already has a disease, we know that aging is going to accelerate that disease process, but sometimes it’s not the most important thing, right? If we have someone who’s diagnosed with diabetes, we’re generally going to say, Hey, fix your HbA1c in your fasting glucose, don’t fix your aging.  Right. So a lot of times, once we [00:22:00] get to disease, this is a secondary consideration manage the disease, but for people who are looking to prevent. disease. So let’s just say someone has Alzheimer’s or a history of neurodegenerative disease in their family. We know that 90 percent of Alzheimer’s risk is age.  So this is absolutely something someone should focus on. 

Dr. Weitz: Yeah, let’s say they have one or two copies of the APOE4 gene.

Ryan Smith: Yeah, exactly. And so the idea would be that the lower that you can get your biological age, the lower your risk of developing early onset Alzheimer’s or any type of dementia. And we know that from multiple association studies.  These DNA methylation clocks, there’s now been over 2000 studies published on these DNA methylation clocks and outcomes. And generally you can find ’em connected to all outcomes. And so the idea would be that we’ll test, see where you’re at, and then make recommendations on how to improve that.

So for instance, let’s just say that you see someone come in, we give them a omic age, we tell ’em that their age is two years older than their chronological age. So they might be. 47 biologically while being 45 chronologically. They’re accelerated aging and we [00:23:00] would want to fix that. So we might recommend things to try and get that down.

Some of those things are pretty intuitive and the things that we know already work for optimal health, right? Exercise, proper diet, nutrition, reducing stress, getting the right amount of sleep, right? Those things are not. Terribly innovative, but they also work, right? And when they work, we see it reflected in reduced ages.

And then so we have that, but we can also make even, I would say, more exotic recommendations based on some of the studies we’re doing. Where hyperbaric oxygen will work, or young plasma would work, or senolytics would work, for instance and starting to make some of those recommendations as well.  So, first you get a baseline, then we will try and implement protocols to reverse that process. And then hopefully as we measure it, we see you continue to reduce that gap and become younger versus your chronological age.

Dr. Weitz: Now, what about personal, personalized recommendations? So with all these things we have some guidelines, but there’s a lot of controversy.  Which is the best diet for each person? Maybe one person’s going to optimize their [00:24:00] biological aging with a vegetarian diet, and the next person’s going to optimize it with any Mediterranean diet. And maybe, is there a way that we can use this testing to say, okay, for you, the vegetarian diet’s helping you to age better?

Ryan Smith:   So, yeah so absolutely. And that’s where these newer algorithms come in. Those epigenetic biomarker proxies from omic age, for instance. So for instance, we might see someone who has really low carotenoid levels, right? Beta carotene levels. We know that beta carotene is associated with better aging across the board.  All of these epigenetic clocks. And even just in regular meta analysis studies, we can say, Hey, someone has really low beta carotene. We need to encourage their consumption of beta carotene. Leafy green vegetables and carrots, right? To increase that metabolite, which we know is going to be, reducing their biological age, reducing inflammatory markers.

So we can absolutely make some specific recommendations like that. Some that are directly related to supplements, right? So, we have, even a metabolite called uridine, which can be supplemented and sold at places like Life [00:25:00] Extension to improve those markers. And so we can certainly make those individual recommendations based on Where you’re elevated and we know that elevation should be low, right?

So if we see your HgA1C is high, or your fasting glucose is high, we know that’s not good for aging. We want to get that lower. We’ll make specific recommendations for you. The other report that we just launched last week was Symphony Age. Symphony age is one we developed with Yale. And although we don’t report on individual biomarkers like hba one C or CRP, we report on aging of different organ systems.

And that’s so that we can actually, again, make more precise recommendations to say that your overall aging might look great, but. Your brain is aging really quickly. We want to try and improve that. So let’s pay attention to the tried and true methods we know to improve brain aging. And so one of the next publications we’ll come out with that same group from Yale, and because I keep mentioning them so much, I want to give them a direct shout out, which is Albert Higgins Chan and I would say his lab, which he took over from Morgan Levine.

Many people might know Morgan Levine. As a famous aging researcher, she’s amazing as well. They’ve created a great culture in that lab and are doing some amazing research. But one of the research [00:26:00] things I also wanted to give a shout out to a PhD student, Raghav Sehgal, as well. He is also doing some work here, but we’re about to publish a paper on 50 plus longitudinal interventional trials with all of the clocks analyzed.

And we’re really excited to do it because it’s a toolkit for both patients as well as physicians on how to best improve these clocks. And so we have some really exciting data coming out there. I’ll just give you a brief picture to show you some of this analysis. But here you can see some of the different analysis that we’re doing, everything from rapamycin to, vegan or healthy vegetarian guidelines.  And we can show what clocks respond and in what direction to give you a cheat sheet. But the one thing we find out is the three best clocks. 

Dr. Weitz: And of course, I see you, you got Ozembic in there. You got semiglutide….

Ryan Smith: Yeah, definitely. And some of these come with caveats. We’re about to publish a huge semiagglutide study as well.   But but yeah the idea being is that we’ll be able to, use the same measuring sticks across trials to then tell you what is the biggest [00:27:00] potential to change your biological age in a positive way versus a negative way. And we’re really excited about that. That’s very cool.

Dr. Weitz: So, the symphony age is now available as part of your program, right?

Ryan Smith: It is, and it is. And so you’ll get with our testing now, a big report. I can just even show you really quickly what that would look like as I sort of talk to you. I know, again, most people are going to be listening so we don’t have to spend a ton of time on it. But we can give you for instance, Your omic age, that’ll tell you your age versus the population.  We’ll track those changes over time. We can even then tell you how your aging is affecting your disease risk. So are accelerated aging leading to increased disease risk of each of these outcomes? We can then tell you what to do about it. So where are you out of range and what would we want to correct?

And then what are those things that most typically correct these different biomarkers? We also give that symphony age again with the age of each organ system and track that longitudinally as well. We give the rate of aging. This is the last of those aging algorithms that I mentioned. It’s the only third generation clock trained [00:28:00] longitudinally over time.

And it’s by far the most responsive to change. So in all of the, those 50 different interventional trials, it was the one that changed the most in measuring Effective change. So we’ll do that. We’ll do your immune cell subset percentages. We’ll do, your telomere length. We’ll tell you how much you’ve smoked and drank across lifetime as well as a few other different reports.  So you get quite a bit of information. Aging is certainly what most people are using this for now, but in the future we see this actually morphing to a diagnostic that can help with all areas of health. Interesting.

Dr. Weitz: What are, so from the interventions that have been done so far you mentioned caloric restriction.  What other things do we know that seem to impact biological aging?

Ryan Smith: Yeah, I would say again a lot of the data that’s out there tells us what we already know, which is not a bad thing. I think that people might say, hey, I see that, Mediterranean diets are super helpful for aging.  That doesn’t, that’s not a huge surprise to most people, right? But the fact that we’re seeing consistency with these measurements to what we already know is actually a [00:29:00] good thing because it shows that we’re on the right track. And so a lot of the things that we know are, Avoiding bad behaviors, right?  Off the bat. And most of you know what those bad behaviors are, right? They’re going to be the smoking and drinking, the processed foods, the lack of exercise, the lack of social connection and relationships, even workplace stress. Even people who work over 40 hours a week are on average 1.5 years older with some of these algorithms than those who are not. So service off stop bad behaviors. And then replace them obviously with good behaviors, getting the right amount of sleep, right? Making sure that. You’re not eating a lot of processed foods or fatty foods.

Making sure that you’re doing all the right things from a diet and nutrition perspective. When we get into the more exotic things, like the protocols, the procedures, the medications the supplements we start to see some different things that are a little bit more exciting. For instance, we’re seeing you know, good improvements with things like hyperbaric oxygen which again is probably not a surprise to a lot of people, but good to be replicated.

We’re seeing the satinib and quercetin again, similitics actually improve the biological aging over time. We’re seeing I, I would say [00:30:00] though, that the thing that jumps out to me time and time again is probably the most reliable therapy are things that inhibit mTOR. So things like caloric restriction, mTOR, this mammalian target of rapamycin is a sort of a master regulator of some of the processes in our cell.

And things that inhibit it generally have better outcomes. And so, Wrapamycin is another example of that. It specifically inhibits this enzyme and has been shown to increase lifespan in dogs by 33 percent in animal trials. recently in a rhesus monkey trial, 15%. And so I would say that, methionine restriction, caloric restriction, rapamycin derivatives, those are all play a big impact in, or one of, I think the most effective solutions we have now.

Dr. Weitz: Now you mentioned mTOR and mTOR has to do with growth and there’s kind of been two trends in longevity, Therapeutics. And one is an older trend and one is a newer trend. And the older trend was to focus on making sure that we [00:31:00] continue to regenerate our tissues. Because we know as we get older that things break down.  The cells break down, things don’t work as well, you lose muscle, you lose bone, we have sarcopenia, osteopenia etc. Brain doesn’t function as well. So We want to use things that stimulate growth and regeneration and we saw a lot of clinics using growth hormone and other hormones, testosterone other therapies that promote regeneration because as you get older, you fall you break a hip, etc.  And that’s a major cause of mortality. And in the last 10, 15 years. We’ve seen more of a trend of people talking about reducing mTOR. Let’s not have too much growth. Let’s make sure we in fact people have pointed to [00:32:00] there’s certain populations like the Laron dwarfs in Ecuador that don’t produce growth hormone.  So having less growth hormone is good. And so we have these two opposite trends, promote growth, regeneration, not lose our strength, not lose our bones, not lose our, or no, we have to reduce growth because growth is associated with cancer and we need to use things that suppress it.  And I’m sure at some point we’ll find out there’s a balance, what’s your sense of those two trends right now?

Ryan Smith: Yeah, I think there certainly is a balance, but I would say that time and time again, I think that we are more on the stop the proliferation than to encourage it. So more of the mTOR inhibition versus the growth pathways, IGF 1 and now in multiple studies, the higher the levels, generally the shorter the lifespan of the first ever animal veterinary pathway for drug approval for longevity is actually an IGF 1 blocker.  In canines. And so [00:33:00] I think that the more the data is coming I think that trying to limit proliferation or growth is generally where the data is pointing. Whereas and so things like rapamycin and mTOR inhibitors are a good way to do that. 

Dr. Weitz: On, on the other hand, the first study that showed reversal of biological aging, the Fahy trial used growth hormone and DHEA as two of its major interventions.

Ryan Smith: Yeah, but it was only in nine patients, all men and and, generally, one of the big problems with that is we know the growth hormone actually does have an effect at regenerating the thymus that immune organ that, that’s 

Dr. Weitz: Which that’s a major factor with aging.  That’s why so many older people die from severe infections is because they have Thymic involution, shrinking of the thymus gland, your immune system gets weaker.

Ryan Smith: Yeah, definitely. And, I think that metformin even if you looked at some of that interventional data, we were talking about in that trial with Yale it looks [00:34:00] good at reversing it.  So it’s hard to say which one is the main leader there, but with nine patients, it’s probably too small of a sample size to even to, to speculate. But with that being said, I think that yeah, I would go probably the mTOR inhibition over AMP kinase and some of those other activation pathways, but but I,

Dr. Weitz: it’s interesting, even some of the top researchers have said, well, yes, reduce IGF1 until you hit age 65, then it’s okay to promote more IGF1.  And this also relates to our recommendations for diet. So for example, Cool. Protein has been associated with promoting, potentially promoting, I don’t know if it’s necessarily as correlated as some people claim, but that it promotes IGF 1. And so therefore you want to have a lower protein intake, more of a vegetarian diet until you hit 65.  Then you want to have more protein because you don’t want the person to fall and break their hip and then they go [00:35:00] downhill from there.

Ryan Smith: Exactly. Frailty is one of the best surrogates we have from an FDA or governmental perspective for aging. And we know that is absolutely impacted by some things like IGF 1.

Dr. Weitz: And it’s also one of the reasons why weight training is so beneficial for aging. Because, that loss of muscle. There are people in nursing homes that can’t get out of bed simply because they’re too weak.

Ryan Smith: Exactly. Yeah. And so there are certainly, I think that’s why instead of looking for individual biomarkers, we really have to look at effective tools, right?  Tools that predict outcomes effectively. And that’s I think what we’re hoping to develop. Otherwise, you can get lost a little bit in every single biomarker that is associated with aging. That’s again, why these hallmarks of aging keep expanding. But we still are, I would say, still, So far away from having an FDA approved drug to treat that process.  And I, by the way, before we get away from this topic, the hyper function theory of aging by Mikkel Blagoslony is one that incorporates both models. I think. Oh, really? Tell me about that. Yeah, this idea that we’re optimized as evolutionarily [00:36:00] for reproduction.

But we never really turn off those developmental pathways. So we keep proliferating, we keep, sort of, growing, but the idea is that with mTOR inhibitors, you can stop or slow that process. And by slowing that process, we will lose function at a much later date. And that’s, so there’s a lot of good data to suggest this.

So for instance, rapamycin, Started earlier in life, generally has better effects than started late in life. So we’re preventing some of that degradation and signal loss versus I would say, trying to treat it once it’s already happened like we would lytics, for instance.

And so I’m a big fan of the hyper function theory of aging as well as this epigenetic information loss theory of aging. Where the instructions to ourselves on how to perform just get a little dysregulated over time whether a result or cause of disease. But yeah, I think that, those, how we manage it clinically is the end of the goal, right?

Are we using growth hormone? Are we doing nine months on mTOR inhibition and three months on, proliferative growth with, trying to improve, growth hormone levels or hormone levels or our NAD levels or whatever it might be. And so we’re trying to come to that, but through a [00:37:00] unified framework and that really means creating tools that we can use as surrogates to gauge this process.

Dr. Weitz: I suspect, even though the trend now is to reduce mTOR, that in the future we’re going to find out that this is a J shaped curve like we see with a lot of things, and having low levels of vitamin D is bad. Having, super high levels of vitamin D is probably not optimal either, and so there’s a J shaped curve where if your your promotion of growth and regeneration is too low, that’s going to be bad, and if it’s too high, that’s going to be bad too.

Ryan Smith: Yeah, definitely. And yeah, and I think we’re just now trying to answer those questions with again, something that’s reliable and reproducible. And I think that yeah we’ll get to some of that. I think in terms of where the best are, but I also want to bring up this idea of, in the future, I think probably the most exciting intervention of them all is this idea of cellular reprogramming.  It is incredibly exciting. And I think will really shift how we think about both disease as well as aging. [00:38:00] So what do we mean by cellular reprogramming? Yeah, so in, in 2012 a scientist named Yamanaka won the Nobel Prize. Oh yes. Yeah, and this is this idea that he was using proteins to take any cell and revert it back into a pluripotent stem cell.

So a cell that was a, for instance, a skin cell could go back and become anything now with that same genetic information. And in doing so, in further research, we’ve also seen that by expressing Yamanaka factors and giving them to cells, they actually epigenetically reset. So they go back to an age of a really young age for instance.

And so the idea would be, can we use those Yamanaka factors to restore function of different cells? And that’s certainly what’s happening now. They’re using Yamanaka factors to, restore vision in blind mice. They’re using Yamanaka factors to improve. Heart Failure in these animal models, it’s a way to go in and reset the instructions for a cell to its, it’s I would say like a hard restart of a computer, right?

Where you’re, going back to the factory [00:39:00] settings and starting from new where then your computer goes a little bit faster, it functions a little bit more like it should. And that’s what’s happening with those Yamanaka factors, is restoring them to the best version of themselves.

Dr. Weitz: Where, what’s the latest on the Yamanaka factors? Where are they starting to be used in humans?

Ryan Smith:  Yeah not in humans just yet. I would say the, I just got back from a trial conference in Barcelona where you’re only allowed to share unpublished data. And over the recent couple of weeks, there’ve been some major breakthroughs here.  Alatost Labs is probably the most notable company in this space. This is a company that got Steve Horvath from UCLA, got Morgan Levine from Yale. Got Yamanaka himself. So they’ve got the who’s who of scientific researchers. And they were funded by Jeff Milner with over 3 billion as a startup.  Oh, really? Yeah. That’s not the usual type of startup money going to some of these areas, but they just released some preliminary data that showed

Dr. Weitz: Horvath’s no longer at UCLA and Morgan Levine’s no longer at Yale.

Ryan Smith: Correct. They’re now with Altos, along with a host of other, Nobel prize [00:40:00] winners and other who’s who of scientists.  And so they’ve got the collection of an amazing team. And with that they just released their initial data and they showed that with a single injection, they’re improving lifespan in mice by 25 percent in over a thousand mice that have been studied. 

Dr. Weitz: A single injection of what?

Ryan Smith: Yeah. They won’t say, that’s what I’m doing, but it is based off of the Yamanaka factors. So based on some of that technology and, that’s an expensive technology, but people are now even finding small molecules that might do it, about Valproic acid is a good example of, a molecule which can cause some reprogramming and people are investigating.  What molecule? Valproic acid, which most people know, for seizure medications, right? Oh, okay. But but people are even using some of those molecules, and so there, there are ways that I think that it might become more accessible, but already it looks to be incredibly promising and the ability to regenerate, I think, as well as restore youthful information.  Fascinating. Yeah, very. It’ll be, I think, one of the biggest breakthroughs in medicine. I’ve always been [00:41:00] very skeptical of this living to 125, 150, but now with these Yamanaka factors, it looks like it’s in sight. Really? Wow. Very fascinating.

Dr. Weitz: And what do you think about the regenerative plasma therapy that’s available out there?

Ryan Smith: Yeah, I think that it’s certainly interesting. We’ve done a couple studies here. We’re about to release one with the Buck Institute and Dobry Kiprov, who’s the father of plasma apheresis. The, I think it all started with this idea that, if you take an old mouse and a young mouse and you hook their vascular systems together, so the heart of the young mouse is pumping blood to the old mouse and the heart of the old mouse is pumping blood to the young mouse.

They saw that the young mouse the older mouse regenerated, right? It got rid of gray hair and improved its muscle mass. It just looked physiologically younger, but on the other end, the younger mouse got older. It started to develop other phenotypic signatures of aging. And so it brought up this idea that maybe there’s something in our blood or plasma That is both causing age to get worse, but also maybe improving that process.

And I think the preliminary data [00:42:00] looks super exciting. There are a lot of different improvements. The problem is it’s really hard to get access to, it’s a little bit expensive. And we also don’t know how often you need to do it to have all the benefits. And so I’m very hopeful about it.  I think the preliminary data looks really good, but I also don’t know how sustainable it is. I also know the FDA doesn’t like plasma. Young plasma transfers as a strategy. So I’m not sure how widely robust it will be, but it certainly looks promising. Right.

Dr. Weitz: Essentially what you do is you go in and they take albumin from a younger person and re take, replace your albumin with that, right?

Ryan Smith: Yeah. So the whole plasma generally they also will supplement with new albumin and albumin is one of those biomarkers we know, again, declines with age and the higher it is generally the better we do. Binds the majority of proteins within your blood. It’s actually the number one factor, or should I say the secondary factor in our omic age algorithm.  It’s weighted that highly. So we know albumin is certainly important and this, it brings up this hallmark of [00:43:00] aging. Proteomic dysregulation that might end up happening as well. And some people estimate that’s why saunas help improve health is by activating heat shock proteins and getting rid of non functional proteins.

So you get, get to see a lot of these same narratives and across this, but yeah, I think it’s certainly an impressive strategy and certainly merits more research. There are a lot of companies now that are basically creating synthetic versions of young plasma that might be more likely to get FDA approved.

Really? Synthetic versions? That sounds a little scary. Yeah. Well, what they basically do is they compile hundreds of thousands of plasma patients and then start to filter segments. And those segments are generally what they’re they’ll give. Alkahest is the company there that’s been doing a lot of that research.  But but yeah, so definitely I think that there are probably ingredients in that plasma that can help improve aging. We’ve just got to find out what they are and then see how we can make it more accessible. And get rid of the parts of

Dr. Weitz: it that are making aging worse, which is the damage that occurs, the old proteins that are [00:44:00] incorporated, et cetera, et cetera.

Ryan Smith: Yeah, and that’s what a lot of people now are doing. Instead of just infusing young plasma, they’re just filtering their own to get rid of some of that stuff. Plasma,

Dr. Weitz: Phoresis, yeah.

Ryan Smith: Exactly. And so we’ll have trials published on both of them coming out relatively soon. That’s,

Dr. Weitz: that’s great. You’re right on the cutting edge of all this stuff and able to offer this test to clinicians and the public.  So how do Clinicians and people watching this find out about getting the is it still called the true age test?

Ryan Smith: Yeah, it is. Yeah. The true age test is something that continually changes for us. We add algorithms as we just did with Symphony Age. We add other insights but they can, the best way to do, it’s to go to our website at true diagnostic.com.

If anyone has any scientific questions about the test, they can always reach out to me personally or our support team atRyan@truediagnostic.com or support@truediagnostic.com. We also have, just a lot of educational [00:45:00] resources. If anyone wants to learn a little bit more to go to our research page, you’ll see some of the research that we’re doing with all of these universities as well, if they want to read a little bit more about it.

Dr. Weitz: And clinicians can sign up to become to offer the tests to their patients as well.

Ryan Smith: Yes, definitely. The we actually specialize with physicians because some of this information is a little hard to interpret and you really need a really big clinical picture. And so that’s why for our main market, and we do lots of education for physicians.  If you’re new to this topic, if you’re new to the idea of DNA methylation, I mentioned that, when I was in med school, And in undergrad I had probably less than a day of epigenetic education and that’s how new and innovative some of this is. And so we do a lot of education on this topic and love to I would say get clinicians up to speed and really try and implement these in clinical practice.

Dr. Weitz: And so when they order, when the test is ordered now, is the symphony age automatically included in that?

Ryan Smith: It is. It is. And generally you get all 11 reports that we do and those reports will continue to be expanded. The next areas that we’re really going to [00:46:00] go into is personalized nutrition. So we can actually tell you the levels of, things like alpha ketoglutarate or vitamin D or your omega threes with that same data set.  And then very soon we’ll also be doing methylation risk scores for disease. So how likely are you to develop these different disease outcomes?

Dr. Weitz: So you’re not going to be measuring the level of vitamin D, you’re measuring epigenetic marks that code for vitamin D levels, right? Is that what you’re doing?  Yeah, exactly. Okay.

Ryan Smith: Yeah, so we’re just using that DNA methylation data to predict surrogates and so we really do believe that in the future we’ll be able with one single fingerprick test, be able to read those DNA methylation patterns to do probably a large majority of the clinical testing that you currently do with a single diagnostic.  And that’s really what we’re excited about. Very exciting. Thank you so much,

Dr. Weitz: Ryan. Yeah, thanks so much. Appreciate it.

 


 

Thank you for making it all the way through this episode of the Rational Wellness Podcast. For those of you who enjoy listening to the Rational Wellness Podcast,  I would very much appreciate it if you could go to Apple Podcasts or Spotify and give us a five star ratings and review.  As you may know, I continue to accept a limited number of new patients per month for functional medicine. If you would like help overcoming a gut or other chronic health condition, and want to prevent chronic problems, and want to promote longevity, please call my Santa Monica Weitz Sports Chiropractic and Nutrition office.  Call us at 310 395 3111 and we can set you up for a consultation for functional medicine. And I will talk to everybody next week.